<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T01:00:31Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7310630" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7310630</identifier>
        <datestamp>2020-06-25</datestamp>
        <setSpec>medrxiv</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">medRxiv</journal-id>
              <journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
              <journal-title-group>
                <journal-title>medRxiv</journal-title>
              </journal-title-group>
              <publisher>
                <publisher-name>Cold Spring Harbor Laboratory</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7310630</article-id>
              <article-id pub-id-type="pmcid">PMC7310630</article-id>
              <article-id pub-id-type="pmc-uid">7310630</article-id>
              <article-id pub-id-type="pmid">32587978</article-id>
              <article-id pub-id-type="pmid">32587978</article-id>
              <article-id pub-id-type="doi">10.1101/2020.06.12.20126391</article-id>
              <article-version-alternatives>
                <article-version article-version-type="status">preprint</article-version>
                <article-version article-version-type="number">3</article-version>
              </article-version-alternatives>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Morozova</surname>
                    <given-names>Olga</given-names>
                  </name>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Zehang Richard</given-names>
                  </name>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Crawford</surname>
                    <given-names>Forrest W.</given-names>
                  </name>
                  <xref ref-type="aff" rid="A3">3</xref>
                  <xref ref-type="aff" rid="A4">4</xref>
                  <xref ref-type="aff" rid="A5">5</xref>
                  <xref ref-type="aff" rid="A6">6</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>1.</label>Program in Public Health and Department of Family, Population and Preventive Medicine, Stony Brook University (SUNY), NY, USA.</aff>
              <aff id="A2"><label>2.</label>Department of Statisitcs, University of California, Santa Cruz, Santa Cruz, CA, USA.</aff>
              <aff id="A3"><label>3.</label>Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.</aff>
              <aff id="A4"><label>4.</label>Department of Statistics &amp; Data Science, Yale University, New Haven, CT, USA.</aff>
              <aff id="A5"><label>5.</label>Department of Ecology &amp; Evolutionary Biology, Yale University, New Haven, CT, USA.</aff>
              <aff id="A6"><label>6.</label>Yale School of Management, New Haven, CT, USA.</aff>
              <author-notes>
                <fn fn-type="con" id="FN1">
                  <p id="P1"><bold>Author contributions</bold>: Conceptualization: FWC, OM; Methodology Development: FWC, OM, ZRL; Software Development: FWC, OM, ZRL; Validation: OM; Formal Analysis: OM, ZRL; Resources: FWC; Data Curation: FWC, OM; Writing – Original Draft: OM; Writing – Review &amp; Editing: FWC, OM, ZRL; Visualization Preparation: FWC, OM, ZRL; Supervision Oversight: FWC; Project Administration: FWC, OM; Funding Acquisition: FWC.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>23</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <elocation-id>2020.06.12.20126391</elocation-id>
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf">nihpp-2020.06.12.20126391.pdf</self-uri>
              <abstract id="ABS1">
                <p id="P2">To support public health policymakers in Connecticut, we developed a county-structured compartmental SEIR-type model of SARS-CoV-2 transmission and COVID-19 disease progression. Our goals were to provide projections of infections, hospitalizations, and deaths, as well as estimates of important features of disease transmission, public behavior, healthcare response, and clinical progression of disease. In this paper, we describe a transmission model developed to meet the changing requirements of public health policymakers and officials in Connecticut from March 2020 to February 2021. We outline the model design, implementation and calibration, and describe how projections and estimates were used to support decision-making in Connecticut throughout the first year of the pandemic. We calibrated this model to data on deaths and hospitalizations, developed a novel measure of close interpersonal contact frequency to capture changes in transmission risk over time and used multiple local data sources to infer dynamics of time-varying model inputs. Estimated time-varying epidemiologic features of the COVID-19 epidemic in Connecticut include the effective reproduction number, cumulative incidence of infection, infection hospitalization and fatality ratios, and the case detection ratio. We describe methodology for producing projections of epidemic evolution under uncertain future scenarios, as well as analytical tools for estimating epidemic features that are difficult to measure directly, such as cumulative incidence and the effects of non-pharmaceutical interventions. The approach takes advantage of our unique access to Connecticut public health surveillance and hospital data and our direct connection to state officials and policymakers. We conclude with a discussion of the limitations inherent in predicting uncertain epidemic trajectories and lessons learned from one year of providing COVID-19 projections in Connecticut.</p>
              </abstract>
              <kwd-group>
                <kwd>SEIR epidemic model</kwd>
                <kwd>SARS-CoV-2</kwd>
                <kwd>social distancing</kwd>
                <kwd>effective reproduction number</kwd>
                <kwd>case detection ratio</kwd>
                <kwd>infection fatality ratio</kwd>
                <kwd>infection hospitalization ratio</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="S1">
              <title>Introduction</title>
              <p id="P3">Epidemiologic models of infectious disease transmission have played an important role in supporting public health decision-making during the COVID-19 pandemic [<xref rid="R1" ref-type="bibr">1</xref>–<xref rid="R7" ref-type="bibr">7</xref>]. By specifying structural features of infection transmission dynamics, models can provide insights into epidemiologic parameters, historical trends in epidemic dynamics, or future outcomes under hypothetical intervention scenarios. Transmission models are especially useful in situations of high uncertainty, offering a structured way to assess the potential effects of interventions given plausible assumptions about disease transmission. Transmission models may also be useful for short-term forecasting: when it is feasible to assume that key epidemiologic features will remain constant over time, such models can provide projections of natural transmission dynamics given the current state of an epidemic. Models cannot predict the future with certainty, but they can be helpful for scenario analysis by bounding the range of plausible future trajectories [<xref rid="R8" ref-type="bibr">8</xref>]. At the same time, simple models may have poor inferential and predictive performance if they fail to capture important features of disease transmission that may vary over time.</p>
              <p id="P4">In early 2020, many countries, including the US, faced a public health crisis caused by the COVID-19 pandemic. In places like New York City and large cities in California, COVID-19 cases increased rapidly. In New York City, severely ill patients overwhelmed hospitals [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>] with death rates as high as 9% among confirmed cases and 32% among hospitalized patients [<xref rid="R11" ref-type="bibr">11</xref>]. Policymakers from the US regions first affected by the pandemic, Connecticut being one of them, were unprepared for its magnitude and severity. In the absence of effective pharmaceutical interventions, state and local governments turned to public health control measures that were last widely used during the 1918 influenza pandemic, such as social distancing and stay-at-home orders, to slow transmission of SARS-CoV-2. As transmission subsided, states began considering phased lifting of social distancing restrictions. Several urgent questions emerged: 1) How soon can interventions like school closures and stay-at-home orders be lifted? 2) How should public health interventions be implemented to minimize the risk of a resurgence? 3) What will be the effect of phased reopening plans on cases, hospitalizations, and deaths? Surveillance data on testing, case counts, hospitalizations, and deaths was useful in characterizing the dynamics of the initial wave, but policymakers needed predictive analytic tools to evaluate the current state of an epidemic and asess the risk of future resurgence.</p>
              <p id="P5">A wide variety of transmission models were developed during the early months of the COVID-19 pandemic. These models were constructed for several related purposes. Many models sought to estimate basic epidemiologic parameters including basic reproduction number (<italic>R</italic><sub>0</sub>), epidemic growth rate and doubling time, serial interval, case and infection fatality ratios, and case detection ratio [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R12" ref-type="bibr">12</xref>–<xref rid="R20" ref-type="bibr">20</xref>]. Some models produced simulated future outcomes under hypothetical behavioral or interventional scenarios [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R21" ref-type="bibr">21</xref>]. Other models had a retrospective inferential goal of estimating effects of past interventions including lockdown and other non-pharmaceutical measures [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R20" ref-type="bibr">20</xref>]. Some early models did not calibrate parameters to data, and instead simulated from models parameterized using published estimates from early observational studies or other infections with similar properties [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R21" ref-type="bibr">21</xref>]. Intervention effects were often included as constant model parameters or estimated by calibrating the model separately to pre- and post-intervention time periods [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. In the early stages of the pandemic, these models helped demonstrate the dangers of unmitigated transmission and provided some evidence of the effectiveness of non-pharmaceutical interventions. However most of these models relied on publicly available data, often limited to official case counts, from the first wave of an epidemic [<xref rid="R12" ref-type="bibr">12</xref>–<xref rid="R20" ref-type="bibr">20</xref>], and assumed constant transition rates (other than reduction in transmission following initial lockdown), and were therefore unable to adequately capture changing features of the COVID-19 burden, including behavioral changes, time-varying policy response, clinical management of the disease, or healthcare system dynamics [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R13" ref-type="bibr">13</xref>–<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R21" ref-type="bibr">21</xref>].</p>
              <p id="P6">As the initial epidemic wave in Connecticut began to subside during the summer of 2020, local policymakers needed models that could answer specific questions about past and current infection dynamics, accommodate established epidemiologic features of disease transmission, permit prediction of outcomes under policy scenarios identified by stakeholders, and provide projections of policy-relevant outcomes under assumptions that could be understood by policymakers. Several nationwide forecasting tools were developed to provide state- or county-level projections, relying on data universally and publicly available across all locations [<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R22" ref-type="bibr">22</xref>]. These models employed assumptions applied universally across all locations and provided a limited set of outputs that were not always able to address the needs of local policymakers. These factors motivated the development of transmission models tailored to local context, the timing of intervention events and planned future policy changes, and data that were only available at the local level [<xref rid="R23" ref-type="bibr">23</xref>–<xref rid="R26" ref-type="bibr">26</xref>].</p>
              <p id="P7">In this paper, we present a county-structured model of SARS-CoV-2 transmission and COVID-19 disease progression in Connecticut. The model was developed and improved over the first year of the pandemic to support decision-making by Connecticut public health officials and policymakers [<xref rid="R27" ref-type="bibr">27</xref>]. This work is the result of continuous feedback from Connecticut public health officials, who provided detailed data on congregate and non-congregate testing, cases, and deaths, age-stratified cases, and hospitalization admissions and census – a feature that is absent from all nationwide analyses. We first describe the epidemic and public policy response in Connecticut, emphasizing the inferential questions articulated by public officials during development of the model. We then briefly describe the structure of the transmission model, its parameters, and data sources used for model calibration, with full details given in the <xref rid="SD1" ref-type="supplementary-material">Supplementary Material</xref>. We present results, including model predictions of hospitalizations and deaths on the dates of important decisions made by policymakers, estimates of the number of COVID-19 infections, case-detection rate, cumulative incidence, effective reproduction number, infection fatality ratio, and other epidemiologic parameters. We conclude with a discussion of the limitations inherent in predicting uncertain epidemic trajectories using models, and outline lessons learned from one year of providing COVID-19 projections to support Connecticut policymakers.</p>
            </sec>
            <sec id="S2">
              <title>The COVID-19 epidemic and response in Connecticut</title>
              <p id="P8">Connecticut (population 3.565 million) was among the US states most severely impacted by the first wave of COVID-19 epidemic [<xref rid="R28" ref-type="bibr">28</xref>]. On March 8th, 2020, the first Connecticut COVID-19 case was reported, followed by a rapid increase in case counts. In the first three weeks of the epidemic, the state reported over 2,500 confirmed COVID-19 cases [<xref rid="R29" ref-type="bibr">29</xref>]. A similar rate of increase in hospitalizations followed, and on April 2, 2020, COVID-19 hospitalization census exceeded 1,000. On March 17, Governor Ned Lamont ordered all in-person classes at K-12 schools canceled, and later extended the closure for the remainder of the 2019–2020 academic year [<xref rid="R30" ref-type="bibr">30</xref>–<xref rid="R33" ref-type="bibr">33</xref>]. The Governor issued a statewide “Stay Safe, Stay Home” order to take effect on March 23 [<xref rid="R34" ref-type="bibr">34</xref>]. The order called on all nonessential businesses to cease in-person operations. Essential businesses could remain open with additional restrictions and guidelines to minimize close contact and risk of transmission. Evidence from mobile device data suggests that Connecticut residents reduced their mobility before the official lockdown order went in effect [<xref rid="R35" ref-type="bibr">35</xref>].</p>
              <p id="P9">The number of hospitalized COVID-19 patients in Connecticut peaked on April 21, 2020 and began a slow decline [<xref rid="R29" ref-type="bibr">29</xref>]. In early May, Governor Lamont issued plans and guidance for reopening, a process set to begin with “Phase 1” on May 20 when some businesses, mostly those operating outdoors, were allowed to reopen at 50% capacity [<xref rid="R36" ref-type="bibr">36</xref>]. Around the same time, we released a report that included COVID-19 transmission projections through August 31, 2020 under different scenarios of potential contact increase during the summer [<xref rid="R27" ref-type="bibr">27</xref>]. Phase 2 of reopening began on June 17th when indoor dining, libraries and religious services were allowed to reopen at reduced capacity [<xref rid="R37" ref-type="bibr">37</xref>]. Reopening was followed by scale-up in testing: average daily number of polymerase chain reaction (PCR) tests increased from about 2,000 at the beginning of April to about 8,000 at the end of June [<xref rid="R29" ref-type="bibr">29</xref>].</p>
              <p id="P10">For most of summer 2020, case counts and hospitalizations in Connecticut remained low, even while large outbreaks were happening in many parts of the US [<xref rid="R29" ref-type="bibr">29</xref>]. The major state-level policy question during this time was whether and how to reopen primary, secondary, and college/university schooling in the fall. At the end of August, we developed model projections of infections, hospitalizations, and deaths for fall under different assumptions about the rate of close interpersonal contact associated with reopening of schools. These forecasts predicted increasing infections and a statewide resurgence during the fall 2020. In-person, remote, and hybrid education at all levels resumed in Connecticut in August and early September. Case counts and hospitalizations during fall 2020 increased slowly [<xref rid="R29" ref-type="bibr">29</xref>], leading the Governor to implement Phase 3 reopening, permitting indoor businesses to operate at higher capacity, on October 8 [<xref rid="R38" ref-type="bibr">38</xref>]. By early November, public health officials recognized a broad statewide epidemic resurgence. In response to rising case counts and fears of a substantial second wave, on November 6 Governor Lamont reverted to “Phase 2.1”, reducing permitted occupancy of indoor businesses and events [<xref rid="R39" ref-type="bibr">39</xref>]. In-person education at most public schools and all universities ended in mid-November before the Thanksgiving recess. Asymptomatic testing programs implemented by many universities were subsequently scaled down, resulting in a reduction in testing rates in Connecticut – making it difficult to interpret changes in the test positive proportion. Case counts in the second wave of the epidemic peaked in mid-December, plateaued for about a month and began a slow decline starting the second half of January 2021.</p>
              <p id="P11">As of mid-March 2021, most schools and universities have reopened with a simultaneous substantial increase in close contact rates. Vaccine deployment in Connecticut began on December 14th, 2020 with residents of congregate settings being vaccinated first. As of March 1, 2021, 8.9% of Connecticut population received full vaccination schedule and 16.5% received at least one dose of the vaccine with most vaccines being administered among residents of congregate settings and in the age group of 75 year old and above [<xref rid="R29" ref-type="bibr">29</xref>].</p>
            </sec>
            <sec id="S3">
              <title>Methods</title>
              <sec id="S4">
                <title>Data sources</title>
                <p id="P12">Our modeling approach relies on multiple data streams provided by the Connecticut Department of Public Health (CT DPH) and the Connecticut Hospital Association (CHA). Some of these datasets are publicly available, while others, including public health surveillance data, were obtained through a contract agreement between CT DPH and the Yale School of Public Health. Baseline non-institutionalized county-level populations and age demographics in Connecticut were obtained from the American Community Survey [<xref rid="R40" ref-type="bibr">40</xref>]. <xref rid="F1" ref-type="fig">Figure 1</xref> shows data series, described below, used in model parametrization and calibration.</p>
              </sec>
              <sec id="S5">
                <title>Hospitalization, deaths, and hospital capacity</title>
                <p id="P13">We obtained data on daily confirmed COVID-19 hospitalization census, cumulative COVID-19 hospitalizations, cumulative number of deaths among hospitalized patients, and daily total available hospital beds (including occupied) in Connecticut from CHA [<xref rid="R41" ref-type="bibr">41</xref>]. Hospitalizations census and deaths time series are available since the epidemic onset in March 2020. CHA changed their data collection and reporting procedures with respect to admissions and discharges in late May 2020, and cumulative hospitalizations data are available starting May 29, 2020. Data on the total number of COVID-19 deaths are publicly available and were obtained from the Connecticut Open Data Portal [<xref rid="R29" ref-type="bibr">29</xref>].</p>
                <p id="P14">The transmission model aims to capture community spread of SARS-CoV-2, and therefore excludes transmission occurring in congregate settings like skilled nursing and assisted living facilities, or prisons. Similar to Salje et al. [<xref rid="R6" ref-type="bibr">6</xref>], we excluded congregate settings, since transmission in small closed communities violates important modeling assumptions related to mixing patterns in the population. Available hospitalization data do not disaggregate by the patient’s place of residence at the time of diagnosis or hospitalization. According to CT DPH, as of October 30, 2020, about 73% of all deaths have occurred among residents of congregate settings, primarily nursing homes, emphasizing that the first wave of the epidemic was heavily dominated by transmission in this population. To address this issue, we estimated the time series of hospitalizations (census and cumulative) and hospital deaths coming from non-congregate settings and used these estimated counts in the model calibration. We received data on daily COVID-19 death counts in hospitals disaggregated by the type of residence (congregate vs. non-congregate) at the time of diagnosis or hospitalization from CT DPH (Plot D in <xref rid="F1" ref-type="fig">Figure 1</xref>). Based on these data, we estimated the time-varying proportion of hospitalization census and cumulative hospitalizations coming from congregate and non-congregate settings. A detailed description of this process is provided in the <xref rid="SD1" ref-type="supplementary-material">Supplement</xref>. Plots B and C in <xref rid="F1" ref-type="fig">Figure 1</xref> show estimates of these time series along with observed total numbers.</p>
                <p id="P15">Data on estimated daily hospital admissions and deaths from non-congregate settings were used to estimate time-varying hospital case fatality ratio (HFR) and used as a time-varying parameter in the transmission model (Plot E in <xref rid="F1" ref-type="fig">Figure 1</xref>). Data on monthly average hospital length of stay among COVID-19 inpatients in Connecticut hospitals were provided by the CHA and used as a time-varying parameter in the transmission model (Plot F in <xref rid="F1" ref-type="fig">Figure 1</xref>).</p>
              </sec>
              <sec id="S6">
                <title>COVID-19 tests, cases, and age distribution of cases</title>
                <p id="P16">We assume that widespread testing shortens the time between infection and diagnosis and may therefore lead to shorter duration of transmissibility via isolation of infected individuals. We use daily PCR testing volume (Plot I in <xref rid="F1" ref-type="fig">Figure 1</xref>) to parameterize the time-varying duration of infectiousness among mildly symptomatic and asymptomatic cases. Data on daily PCR tests were obtained from the Connecticut Open Data Portal [<xref rid="R29" ref-type="bibr">29</xref>].</p>
                <p id="P17">We used the proportion of daily confirmed COVID-19 cases aged 60 years old and above to parameterize the dynamics of severe infections over time (Plot H in <xref rid="F1" ref-type="fig">Figure 1</xref>). Early in the epidemic, testing was not widely available and was primarily used to confirm severe cases that were more likely to be among older people. Therefore, in model parametrization, we assume a constant severe proportion early in the epidemic, and use these data to approximate changing severity proportion beyond the second phase of reopening, which started on June 17, 2020, when testing became widely available (vertical dashed line in Plot H in <xref rid="F1" ref-type="fig">Figure 1</xref>). Plot A in <xref rid="F1" ref-type="fig">Figure 1</xref> shows reported case counts in Connecticut by residence type (congregate or non-congregate).</p>
              </sec>
              <sec id="S7">
                <title>Close interpersonal contact</title>
                <p id="P18">Close interpersonal contact (within six feet) is the main route for transmission of SARS-CoV-2 [<xref rid="R42" ref-type="bibr">42</xref>]. Social distancing interventions implemented in Connecticut were intended to reduce the frequency of such contact. We therefore estimated the frequency of close interpersonal contact everywhere in Connecticut using mobile device geolocation data. The project, described separately by Crawford et al. [<xref rid="R43" ref-type="bibr">43</xref>], developed a novel probabilistic measure of contact and aggregated contact events at the town and state levels to describe the dynamics of close interpersonal contact. Plot G in <xref rid="F1" ref-type="fig">Figure 1</xref> shows that statewide close contact in Connecticut dropped from its February 2020 baseline about one week prior to the Governor’s stay-at-home order, and rose slowly throughout the summer and fall.</p>
              </sec>
              <sec id="S8">
                <title>Compartmental model</title>
                <p id="P19">We developed a deterministic compartmental model of SARS-CoV-2 transmission and COVID-19 disease progression. The model is based on the SEIR (susceptible, exposed, infectious, removed) framework [<xref rid="R44" ref-type="bibr">44</xref>], which we extend to accommodate geographical variation in Connecticut, hospital capacity, and distinctive features of COVID-19 disease. The model is implemented at the level of individual counties in Connecticut and assumes that most transmission occurs within a given county. A small proportion of contacts (1.5%) is allowed to happen between adjacent counties.</p>
                <p id="P20"><xref rid="F2" ref-type="fig">Figure 2</xref> shows a schematic representation of the transmission model structure within a single county, the county map of Connecticut [<xref rid="R45" ref-type="bibr">45</xref>], and the county adjacency matrix.</p>
                <p id="P21">We categorize infections as asymptomatic (<italic>A</italic>), mild symptomatic (<italic>I</italic><sub><italic>M</italic></sub>), and severe (<italic>I</italic><sub><italic>S</italic></sub>). Only severe infections may lead to death (<italic>D</italic>). Severe infections are defined as those requiring hospitalization (<italic>H</italic>). If hospitalization capacity is overwhelmed, severe cases in the community are denied hospitalization (<inline-formula><mml:math id="M10"><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula>), and experience a higher probability of death compared to hospitalized cases. Mild symptomatic cases are assumed to self-isolate shortly after they develop symptoms (<italic>R</italic><sub><italic>M</italic></sub>) and remain isolated until they recover (<italic>R</italic>). The average time that severe cases spend in the infectious state is approximated by the time between onset of infectiousness and hospitalization (or attempted hospitalization in case of hospital overflow). The force of infection from hospitalized patients to unhospitalized susceptible individuals is assumed to be negligible. We further assume that recovered individuals remain immune to reinfection for the duration of the study period. Let <italic>N</italic><sub><italic>i</italic></sub> be the population size of county <italic>i</italic> and let <italic>J</italic><sub><italic>i</italic></sub> be the set of counties adjacent to county <italic>i</italic>. Let <italic>C</italic><sup>(<italic>i</italic>)</sup> represent hospitalization capacity in county <italic>i</italic>, which may vary over time. Transmission dynamics in county <italic>i</italic> are given by the following system of ordinary differential equations:
<disp-formula id="FD1"><label>(1)</label><mml:math id="M11"><mml:mrow><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:munder><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:munder><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mi>δ</mml:mi><mml:msup><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mi>δ</mml:mi><mml:msup><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mi>δ</mml:mi><mml:msup><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msubsup><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>−</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mi>δ</mml:mi><mml:msup><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>η</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>−</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>H</mml:mi></mml:msub><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msup><mml:mi>η</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>−</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:msub><mml:msup><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mi>D</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>H</mml:mi></mml:msub><mml:msub><mml:mi>m</mml:mi><mml:mi>H</mml:mi></mml:msub><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:msub><mml:msub><mml:mi>m</mml:mi><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:msub><mml:msup><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mspace linebreak="newline"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:msup><mml:mi>A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>H</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>H</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="M12"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>. The function <italic>η</italic><sup>(<italic>i</italic>)</sup> = [1 + exp(0.5(<italic>C</italic><sup>(<italic>i</italic>)</sup> − <italic>H</italic><sup>(<italic>i</italic>)</sup>))]<sup>−1</sup> is a “soft” hospitalization capacity overflow function. <xref rid="T1" ref-type="table">Table 1</xref> lists model parameters and their definitions. The analysis was performed using the R statistical computing environment [<xref rid="R46" ref-type="bibr">46</xref>, <xref rid="R47" ref-type="bibr">47</xref>].</p>
                <p id="P22">Our transmission model does not include effects of vaccination, which began on December 14th, 2020. Initial vaccine deployment in Connecticut prioritized residents of congregate settings and individuals in the age group 75 years old and above. According to the CDC, COVID-19 vaccines achieve their full effectiveness 14 days after the second dose in a 2-dose series or a single dose in a 1-dose series [<xref rid="R48" ref-type="bibr">48</xref>]. As of March 1, 2021, about 5% of non-congregate population in Connecticut were fully vaccinated. Given that some of these people may have already experienced SARS-CoV-2 infection, that the majority of them were older people who do not mix as much as younger working-age population, and that the proportion vaccinated is within the uncertainty bounds of the cumulative incidence, vaccine effects before March 1, 2021 are unlikely to have a substantial impact on model projections. At the same time, some of the vaccine effects, such as incidence and case fatality reduction among older people are captured in the dynamics of time-varying model parameters. As vaccination coverage among young and working-age individuals increases, it will become important to incorporate vaccine effects in the transmission model.</p>
              </sec>
            </sec>
            <sec id="S9">
              <title>Time-varying model parameters</title>
              <sec id="S10">
                <title>Transmission rate <italic>β</italic></title>
                <p id="P23">Social distancing practices may reduce the value of the transmission rate <italic>β</italic>. We use data on close interpersonal contact in Connecticut for the entire duration of the modeling period [<xref rid="R43" ref-type="bibr">43</xref>], and assume the following functional form for the transmission rate:
<disp-formula id="FD2"><mml:math id="M13"><mml:mrow><mml:mi>β</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mtext>contact</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mtext> exp</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>B</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where <italic>M</italic><sub>contact</sub>(<italic>t</italic>) is a smoothed normalized measure of close interpersonal contact at time <italic>t</italic> relative to the pre-epidemic level (February 1st - March 12th, 2020), and exp[<italic>B</italic>(<italic>t</italic>)] is a function that approximates residual changes in transmission parameter <italic>β</italic> that are not explained by changes in close contact and other time-varying parameters. Here, <italic>B</italic>(<italic>t</italic>) is a smooth function obtained by applying spline smoothing on a piecewise linear function <italic>B</italic>*(<italic>t</italic>), where <italic>B</italic>*(<italic>t</italic>) is modeled with <inline-formula><mml:math id="M14"><mml:mrow><mml:msup><mml:mi>B</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>ϵ</mml:mi><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>w</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mn>14</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> defined on bi-weekly knots <italic>w</italic> = {<italic>t</italic><sub>0</sub>, <italic>t</italic><sub>0</sub> + 14, <italic>t</italic><sub>0</sub> + 28, …} over the observation period and linearly imputed between the knots. The <xref rid="SD1" ref-type="supplementary-material">Supplement</xref> shows plots of functions <italic>M</italic><sub>contact</sub>(<italic>t</italic>) and <italic>B</italic>(<italic>t</italic>). We model the vector of random effects <bold><italic>ϵ</italic></bold> using a random walk of order one:
<disp-formula id="FD3"><mml:math id="M15"><mml:mrow><mml:msub><mml:mi>ϵ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:msub><mml:mi>ϵ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>ϵ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>ϵ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ϵ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula>
For the hyperparameter <inline-formula><mml:math id="M16"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ϵ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula>, we use Inverse-Gamma(<italic>a</italic><sub><italic>ϵ</italic></sub>, <italic>b</italic><sub><italic>ϵ</italic></sub>) prior with a shape parameter <italic>a</italic><sub><italic>ϵ</italic></sub> = 2.5 and a rate parameter <italic>b</italic><sub><italic>ϵ</italic></sub> = 0.1. The function <italic>B</italic>(<italic>t</italic>) is also used to set <italic>β</italic>(<italic>t</italic>) in the future to test scenarios and potential intervention effects.</p>
              </sec>
              <sec id="S11">
                <title>Rates of isolation and recovery: <inline-formula><mml:math id="M17"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <italic>α</italic><sub><italic>A</italic></sub></title>
                <p id="P25">Widespread testing and contact tracing efforts can potentially reduce duration of infectiousness. While there is no information about the effectiveness of specific testing efforts implemented in Connecticut, the model accommodates the possibility of such reduction as a function of daily testing volume:
<disp-formula id="FD4"><mml:math id="M18"><mml:mrow><mml:mi>α</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mtext>testing</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>τ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where <italic>τ</italic> is the size of testing effect per unit increase in testing volume measure <italic>M</italic><sub>testing</sub>(<italic>t</italic>) modeled as:
<disp-formula id="FD5"><mml:math id="M19"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mtext>testing</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>log</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mtext>testing</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mtext>log</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mtext>testing</mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>t</mml:mi><mml:mo>&gt;</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mtext> and </mml:mtext><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mtext>testing</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>≥</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mtext>testing</mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>otherwise</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula>
<italic>v</italic><sub>testing</sub>(<italic>t</italic>) is a spline-smoothed measure of testing volume at time <italic>t</italic>. Testing efforts early in the epidemic were primarily used to confirm severe and highly symptomatic infections, and were unlikely to have any appreciable impact on overall duration of infectiousness. Early response daily testing volume is denoted by <italic>v</italic><sub>testing</sub>(<italic>t</italic>*). The <xref rid="SD1" ref-type="supplementary-material">Supplement</xref> shows the plot of function <italic>M</italic><sub>testing</sub>(<italic>t</italic>). This approach is used to model time-varying rates <inline-formula><mml:math id="M20"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> &gt; and <italic>α</italic><sub><italic>A</italic></sub>(<italic>t</italic>) with <inline-formula><mml:math id="M21"><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:math></inline-formula> and <italic>τ</italic><sub><italic>A</italic></sub> = 0.5<italic>τ</italic>. The rate <inline-formula><mml:math id="M22"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is assumed to remain constant over time.</p>
              </sec>
              <sec id="S12">
                <title>Severe fraction <inline-formula><mml:math id="M23"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula></title>
                <p id="P26">The probability of severe infection increases with age [<xref rid="R49" ref-type="bibr">49</xref>]. Age distribution of confirmed cases in the US has shifted toward younger people in the summer compared to spring [<xref rid="R50" ref-type="bibr">50</xref>]. We model the time-varying proportion of infections that are severe as:
<disp-formula id="FD6"><mml:math id="M24"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mtext>severity</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where measure of severity <italic>M</italic><sub>severity</sub>(<italic>t</italic>) is a normalized spline-smoothed proportion of cases 60+ years old among all cases detected at time <italic>t</italic> relative to a baseline level. Since testing availability affects this proportion, we assume that <italic>M</italic><sub>severity</sub>(<italic>t</italic>) = 1 for all <italic>t</italic> &lt; <italic>t</italic>*, where <italic>t</italic>* denotes the time when testing became widely available. The <xref rid="SD1" ref-type="supplementary-material">Supplement</xref> shows the plot of function <italic>M</italic><sub>severity</sub>(<italic>t</italic>). Since <inline-formula><mml:math id="M25"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, we also model <italic>q</italic><sub><italic>A</italic></sub> and <inline-formula><mml:math id="M26"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> as functions of time.</p>
              </sec>
              <sec id="S13">
                <title>Rate of hospital discharge <italic>γ</italic><sub><italic>H</italic></sub></title>
                <p id="P27">We estimate the time-varying rate of hospital discharge <italic>γ</italic><sub><italic>H</italic></sub>(<italic>t</italic>) (including deaths and alive discharges) as a reciprocal of the average length of hospital stay at time <italic>t</italic>, which has been inversely correlated with the incidence of COVID-19. The average length of hospital stay at time <italic>t</italic> is approximated using a spline-smoothed monthly averages of this quantity and is provided in the <xref rid="SD1" ref-type="supplementary-material">Supplement</xref>.</p>
              </sec>
              <sec id="S14">
                <title>Hospital case fatality ratio <italic>m</italic><sub><italic>H</italic></sub></title>
                <p id="P28">Overall and hospital case fatality ratios may vary over time for various reasons. We model HFR as:
<disp-formula id="FD7"><mml:math id="M27"><mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mi>H</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mrow><mml:mi>H</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mtext>HFR</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where <italic>M</italic><sub>HFR</sub>(<italic>t</italic>) is a normalized spline-smoothed HFR at time <italic>t</italic> relative to the baseline HFR = <italic>m</italic><sub><italic>H</italic>,0</sub>. HFR is calculated as a ratio of hospital deaths at time <italic>t</italic> to hospital admissions at time (<italic>t</italic> − HLOS(<italic>t</italic>)), where HLOS(<italic>t</italic>) is an average hospital length of stay at time <italic>t</italic>. The <xref rid="SD1" ref-type="supplementary-material">Supplement</xref> shows the plot of function <italic>M</italic><sub>HFR</sub>(<italic>t</italic>).</p>
              </sec>
              <sec id="S15">
                <title>Model calibration and Bayesian posterior inference</title>
                <p id="P29">We calibrate the posterior distribution of model parameters to estimated hospitalizations and hospital deaths coming from non-congregate settings using a Bayesian approach. Sampling from the joint posterior distribution of calibrated model parameters is performed using Markov Chain Monte Carlo. The Supplement provides detailed description of the data likelihood, calibration approach, sampling algorithm, implementation, and results, including convergence and estimated joint posterior distribution of model parameters, as well as description of prior distributions along with data sources. Source code and aggregated data used to produce model projections are available from <ext-link ext-link-type="uri" xlink:href="https://github.com/fcrawford/covid19_ct">https://github.com/fcrawford/covid19_ct</ext-link>. To generate model projections, we sample from the joint posterior distribution of estimated parameters, simulate transmission dynamics for a given combination of parameters, and compute pointwise averages (means or medians) and posterior predictive intervals for each time point.</p>
              </sec>
              <sec id="S16">
                <title>Ethics statement</title>
                <p id="P30">This analysis does not use patient-level data with personal identifiers.</p>
              </sec>
            </sec>
            <sec id="S17">
              <title>Results</title>
              <sec id="S18">
                <title>Estimates of epidemiologic features</title>
                <p id="P31"><xref rid="F3" ref-type="fig">Figure 3</xref> shows the results of model calibration along with estimates of important epidemiologic parameters for the period between March 1, 2020 - March 1, 2021. Plots of hospitalizations, effective reproduction number (<italic>R</italic><sub>eff</sub>), and cumulative incidence are overlaid with the dates of Governor’s interventions, reopening of schools and universities in the fall and winter, and the starting date of vaccination campaign. Model fit to observed dynamics of hospitalizations and deaths shows that data points track with mean projections and largely fall within uncertainty intervals.</p>
                <p id="P32">We estimate that <italic>R</italic><sub>eff</sub> dropped substantially in mid-March and remained below one through mid-June. For the rest of the summer, mean estimated <italic>R</italic><sub>eff</sub> was slightly above one consistent with low numbers of case counts and hospitalizations in the summer. A major increase of <italic>R</italic><sub>eff</sub> started in mid-August and continued with the reopening of schools and colleges. It reached a maximum mean value of 1.45 by mid-October, followed by a slow decline through the rest of the year. A second increase in <italic>R</italic><sub>eff</sub> started at the end of January 2021 as schools and universities reopened for the spring semester. The dynamics of <italic>R</italic><sub>eff</sub> follows closely the dynamics of close contact. Plot F in <xref rid="F3" ref-type="fig">Figure 3</xref> shows that the estimated dynamics of transmission parameter captured by a community contact function (measure of close contact adjusted for estimated random effects) exhibits small deviations from the measure of close contact. Our estimate of <italic>R</italic><sub>0</sub> is 4.7 (95%CI: 4.3 – 5.1), consistent with estimates reported elsewhere [<xref rid="R51" ref-type="bibr">51</xref>, <xref rid="R52" ref-type="bibr">52</xref>]. However, this estimate depends on assumptions about initial conditions and is not identifiable from the shape of early exponential increase alone.</p>
                <p id="P33">We estimate that cumulative incidence at the beginning of June 2020 was 5.2% (95%CI: 3.6 – 6.8%) consistent with the results of community-based seroprevalence surveys conducted in Connecticut between April and June [<xref rid="R53" ref-type="bibr">53</xref>, <xref rid="R54" ref-type="bibr">54</xref>] and other local modeling efforts that included Connecticut [<xref rid="R55" ref-type="bibr">55</xref>]. We estimate that as of March 1, 2021, cumulative incidence in Connecticut was about 21% (95%CI: 18 – 24%), which implies a cumulative case detection ratio of 36% (95%CI: 26 – 54%). Our estimates suggest that the case detection ratio varied substantially over time in a way that is not explained by the volume of PCR testing alone (plot I in <xref rid="F3" ref-type="fig">Figure 3</xref>). An increase up to 80% in mid-May may be due to delayed testing, including postmortem diagnosis of first epidemic wave cases. The second spike in estimated case detection ratio in early January may be a consequence of testing and reporting disruptions related to the Christmas and New Year holidays.</p>
                <p id="P34">We estimate the cumulative infection fatality ratio (IFR) to be 1.06% (95% CI: 0.93 – 1.24%) and the cumulative infection hospitalization ratio (IHR) to be 4.1% (95% CI: 3.6 – 4.7%). These estimates are based on data from all recorded deceased and hospitalized individuals, including those residing in congregate settings. Estimated IFR and IHR among residents of non-congregate settings are 0.43% (95% CI: 0.38 – 0.50%) and 3.4% (95% CI: 3.0 – 4.0%) respectively, which are somewhat lower than previously estimated in Connecticut [<xref rid="R56" ref-type="bibr">56</xref>], but are consistent with studies conducted elsewhere [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R49" ref-type="bibr">49</xref>, <xref rid="R57" ref-type="bibr">57</xref>].</p>
              </sec>
              <sec id="S19">
                <title>Predictive performance of the model</title>
                <p id="P35">We illustrate predictive performance of the model by calibrating it to data up to several time points and producing projections of hospitalizations and deaths for the next two months. Projections into the future are simulated by propagating the latest available values of time-varying parameters into the future. A forecasting time horizon of two months is shown. Longer-term projections were less useful due to anticipated changes in policy, public behavior, and time-varying parameters. The time points were selected based on important events, such as reopening phases, as well as distinct stages of the epidemic. <xref rid="F4" ref-type="fig">Figure 4</xref> shows calibrations results, projections and actual data over the prediction period for the following calibration cut-off dates: May 20, 2020 (Phase 1 of reopening), June 17, 2020 (Phase 2 of reopening), September 1, 2020 (reopening of schools and colleges), October 15, 2020 (early indications of resurgence), and December 15, 2020 (early indications of the curve flattening during the second epidemic wave).</p>
                <p id="P36">These results show that projections become more accurate as data accrue, and that uncertainty intervals are generally tighter during periods of epidemic decline, when the upper bound of uncertainty interval for projected <italic>R</italic><sub>eff</sub> is below one. In early stages, our projections predicted higher hospitalization census compared to what was observed during summer 2020. The main reason for this mismatch is a sharp decline in severe infections proportion that was observed after the initial epidemic wave subsided, as well as the decline in the average length of hospital stay among hospitalized COVID-19 patients (plots H and F in <xref rid="F1" ref-type="fig">Figure 1</xref>).</p>
              </sec>
              <sec id="S20">
                <title>Discussion: transmission modeling in the COVID-19 pandemic</title>
                <p id="P37">As COVID-19 pandemic emerged, policymakers in many parts of the US and across the globe had to make quick decisions under high uncertainty. Access to reliable information about both the current state of the local epidemic and likely future outcomes is an important foundation to support policymakers in this process. Elected officials and public health agencies already have access to near real-time information about COVID-19 testing, case counts, hospitalizations, and deaths. However, these data may not provide timely insight into the current and future dynamics of COVID-19 transmission. Mathematical modeling of infectious diseases offers one way to address these questions, but is subject to limitations that may be difficult to communicate to policymakers. During our year-long collaboration with CT DPH, we learned several lessons in the process of developing, deploying, calibrating, revising, and communicating the outputs of COVID-19 transmission model to policymakers in Connecticut.</p>
              </sec>
              <sec id="S21">
                <title>Transmission dynamics in congregate settings may bias model-based estimates</title>
                <p id="P38">Observable features of the initial epidemic wave in Connecticut - hospitalizations and deaths - were dominated by residents of skilled nursing and assisted living facilities [<xref rid="R29" ref-type="bibr">29</xref>]. In our initial efforts to model outcomes under the state’s stated reopening plans in May of 2020, we did not isolate transmission in congregate settings and treated all hospitalizations and deaths as those arising from a homogeneous mixing process within Connecticut population [<xref rid="R27" ref-type="bibr">27</xref>]. Transmission dynamics in congregate settings among higher risk individuals violate the homogeneous mixing assumption underlying compartmental modeling approaches. Merging cases, hospitalizations and deaths from congregate and non-congregate settings may bias estimates of <italic>R</italic><sub>eff</sub> and result in over-estimation of cumulative incidence, transmission potential, and infection fatality ratio. Recognizing this, we modified the model to only include residents of non-congregate settings.</p>
              </sec>
              <sec id="S22">
                <title>Detailed local data are necessary to capture time-varying epidemic features</title>
                <p id="P39">Similar to many early transmission models that only used data from the first epidemic wave [<xref rid="R13" ref-type="bibr">13</xref>–<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R19" ref-type="bibr">19</xref>], the first version of our model did not incorporate any temporal variation in the input parameters and included constant effects of school closure and lockdown [<xref rid="R27" ref-type="bibr">27</xref>]. However, as the data accrued, constant parameter values failed to achieve a good fit to the observed data. Our collaboration with CT DPH allowed us access to detailed local data informing time-varying model parameters. Incorporating time trends in important epidemic features like close interpersonal contact, risk profile of incident cases, hospital length of stay, and hospital case fatality ratio substantially improved model fit to observed data and its predictive performance. One of the limitations of our model is that it does not incorporate vaccination effects. However, during the modeling period ending on March 1, 2021 these effects are likely negligible in non-congregate residents due to low overall coverage that is primarily driven by an older age group, and are partially captured in the dynamics of time-varying parameters. As vaccination coverage increases, it will be important to include vaccination effects in the transmission model.</p>
              </sec>
              <sec id="S23">
                <title>Anticipated changes in time-varying epidemic features warrant scenario analysis</title>
                <p id="P40">The most substantial changes in time-varying model parameters occurred as the first epidemic wave began to subside in early summer 2020. <xref rid="F4" ref-type="fig">Figure 4</xref> illustrates modest predictive performance of our model during early stages. In this example, future projections are made by propagating the last observed value of time-varying model parameters into the future. When substantial changes in epidemic features are anticipated in the future, scenario analysis may offer a better way to represent the true uncertainty.</p>
              </sec>
              <sec id="S24">
                <title>Close interpersonal contact drives transmission</title>
                <p id="P41">One of the most important data sources that substantially improved our model performance is a measure of close interpersonal contact based on mobile device data. This is a novel metric, whose dynamics exhibit different behavior from that observed in several publicly available mobility metrics, such as maximum distance traveled or time spent away from home, which mostly returned to their baseline values by mid-summer 2020 [<xref rid="R43" ref-type="bibr">43</xref>]. Combined with other time-varying parameters, the close contact metric captured most of the variation in transmission over time. While our approach to use random effects to capture residual variation in transmission dynamics proved feasible and useful, the shape of the resulting contact function exhibits small deviations from the dynamics of close interpersonal contact (plot F in <xref rid="F3" ref-type="fig">Figure 3</xref>).</p>
              </sec>
              <sec id="S25">
                <title>Timing of interventions may not always reflect timing of behavioral changes</title>
                <p id="P42">Public perception of risk appears to be an important time-dependent confounder that is hard to measure or predict. Behavior changes that drive transmission, such as social distancing or mask wearing, may not coincide in time with respective interventions. In Connecticut, close interpersonal contact dropped substantially before the lockdown order went in effect and started rebounding before it was lifted. Many transmission models [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>], including the early version of our model [<xref rid="R27" ref-type="bibr">27</xref>] assume constant intervention effects that modify a given set of parameters at the time of their enactment. Measuring critical features of transmission directly improves model-based projections and offers insights into the estimation of intervention effects.</p>
              </sec>
              <sec id="S26">
                <title>Case counts may be an unreliable proxy for infections</title>
                <p id="P43">Policymakers often rely on case counts and test positive proportion as direct measures of infection incidence. Even though dynamics of detected cases may be a reasonable qualitative indicator of disease incidence, we found that its usefulness for modeling purposes is limited. It is widely recognized that detected case counts depend on the underlying infection incidence and testing volume [<xref rid="R24" ref-type="bibr">24</xref>, <xref rid="R58" ref-type="bibr">58</xref>], however we found that changes in testing strategies and human behavior may lead to non-monotonic relationship between testing volume and case detection rate. Since case counts dynamics are usually widely available across geographic locations, and are often among a few data sources easily accessible by researchers, many nationwide models rely on case counts, possibly adjusting for testing volume [<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R22" ref-type="bibr">22</xref>]. Our experience shows that this approach may be misleading. We therefore chose to rely on hospitalizations and death data for model calibration as these epidemic features are less susceptible to unmeasured time-varying confounding.</p>
              </sec>
              <sec id="S27">
                <title>Incorporating diverse data sources improves credibility of model-based inferences</title>
                <p id="P44">Our modeling projections have been one of the many analytic products informing policy response in Connecticut along with surveillance data on case counts, testing volume and test positive proportion, trends in emergency department visits presenting symptoms of COVID-like illness, outbreak investigations, wastewater monitoring [<xref rid="R28" ref-type="bibr">28</xref>], and trends in close interpersonal contact [<xref rid="R43" ref-type="bibr">43</xref>] among others. For a variety of reasons, it can be difficult for public health decision-makers to enact policy responses based on predictions about the future from transmission models. However, when model projections tell a cohesive story in combination with other analytic products, they may fill in missing pieces and offer insights into the current and future epidemic dynamics.</p>
              </sec>
            </sec>
            <sec id="S28">
              <title>Conclusions and limitations</title>
              <p id="P45">Our year-long effort to provide policymakers with predictions of COVID-19 dynamics in Connecticut showed that standard SEIR-type transmission models work best in large well-mixing populations with constant transmission rates and without major external shocks, like interventions or importation of infections. In order to make valid inferences, it is necessary to incorporate temporal changes in model parameters reflecting interventions, human behavior, heterogeneity in mixing patterns, and measurement errors. Given geographic heterogeneity in the dynamics of these features, models that incorporate contextual information and local data are needed to support local policymakers. While modeling approach described in this paper captures many important features of epidemic dynamics that are often omitted in simpler SIR-type models, our model could be extended to reflect more granular geographic variation, age structure and contact patterns between different age groups, vaccination effects, and other time-varying features of COVID-19 epidemic. When it works best, modeling provides heuristics, guidance, and what-if scenarios for the future offering insights that are otherwise unavailable.</p>
            </sec>
            <sec sec-type="supplementary-material" id="SM1">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="SD1">
                <label>1</label>
                <media xlink:href="NIHPP2020.06.12.20126391-supplement-1.pdf" orientation="portrait" id="d39e2754" position="anchor"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="S29">
              <title>Acknowledgements:</title>
              <p id="P46">We are grateful to Jacqueline Barbieri, Maciej F. Boni, Jessica Brockmeyer, Jared Campbell, Matthew Cartter, Alexandra Edmundson, Hanna Ehrlich, Deidre Gifford, Sydney A. Jones, Edward H. Kaplan, Patrick Kenney, Alison Kleppinger, Albert Ko, Terry Rabatsky-Ehr, Olivia Schultes, Lynn Sosa, and Thomas Valleau. We thank Whitespace Solutions Ltd for providing the contact data. We thank the Connecticut Hospital Association for providing data on COVID-19 hospitalizations and deaths. We thank Connecticut Department of Public Health for providing detailed data on testing, cases and deaths. We thank Stony Brook Research Computing and Cyberinfrastructure, and the Institute for Advanced Computational Science at Stony Brook University for access to the high-performance SeaWulf computing system.</p>
              <sec id="S30">
                <title>Funding:</title>
                <p id="P47">This work was supported by NIH grants NICHD 1DP2HD091799–01, Cooperative Agreement 6NU50CK000524–01 from the Centers for Disease Control and Prevention, funds from the COVID-19 Paycheck Protection Program and Health Care Enhancement Act, and the Pershing Square Foundation. Computing resources at Stony Brook University were funded by National Science Foundation grant # 1531492.</p>
              </sec>
            </ack>
            <fn-group>
              <fn fn-type="COI-statement" id="FN2">
                <p id="P48"><bold>Competing interests:</bold> FWC is a paid consultant to Whitespace Solutions.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>[1]</label>
                <mixed-citation publication-type="web"><name><surname>Ferguson</surname><given-names>Neil M</given-names></name>, <name><surname>Laydon</surname><given-names>Daniel</given-names></name>, <name><surname>Nedjati-Gilani</surname><given-names>Gemma</given-names></name>, <name><surname>Imai</surname><given-names>Natsuko</given-names></name>, <name><surname>Ainslie</surname><given-names>Kylie</given-names></name>, <name><surname>Baguelin</surname><given-names>Marc</given-names></name>, <name><surname>Bhatia</surname><given-names>Sangeeta</given-names></name>, <name><surname>Boonyasiri</surname><given-names>Adhiratha</given-names></name>, <name><surname>Zulma Cucunubá</surname><given-names>Gina Cuomo-Dannenburg</given-names></name>, <name><surname>Dighe</surname><given-names>Amy</given-names></name>, <name><surname>Dorigatti</surname><given-names>Ilaria</given-names></name>, <name><surname>Fu</surname><given-names>Han</given-names></name>, <name><surname>Gaythorpe</surname><given-names>Katy</given-names></name>, <name><surname>Green</surname><given-names>Will</given-names></name>, <name><surname>Hamlet</surname><given-names>Arran</given-names></name>, <name><surname>Hinsley</surname><given-names>Wes</given-names></name>, <name><surname>Okell</surname><given-names>Lucy C</given-names></name>, <name><surname>van Elsland</surname><given-names>Sabine</given-names></name>, <name><surname>Thompson</surname><given-names>Hayley</given-names></name>, <name><surname>Verity</surname><given-names>Robert</given-names></name>, <name><surname>Volz</surname><given-names>Erik</given-names></name>, <name><surname>Wang</surname><given-names>Haowei</given-names></name>, <name><surname>Wang</surname><given-names>Yuanrong</given-names></name>, <name><surname>Walker</surname><given-names>Patrick GT</given-names></name>, <name><surname>Walters</surname><given-names>Caroline</given-names></name>, <name><surname>Winskill</surname><given-names>Peter</given-names></name>, <name><surname>Whittaker</surname><given-names>Charles</given-names></name>, <name><surname>Donnelly</surname><given-names>Christl A</given-names></name>, <name><surname>Riley</surname><given-names>Steven</given-names></name>, <name><surname>Ghani</surname><given-names>Azra C</given-names></name>, and <collab>Imperial College COVID-19 Response Team</collab>. <source>Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand</source>. <year>2020</year>. doi: <pub-id pub-id-type="doi">10.25561/77482</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf">https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R2">
                <label>[2]</label>
                <mixed-citation publication-type="journal"><name><surname>Adam</surname><given-names>David</given-names></name>. <article-title>Special report: The simulations driving the world’s response to COVID-19</article-title>. <source>Nature</source>, <volume>580</volume>(<issue>7803</issue>): <fpage>316</fpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32242115</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>[3]</label>
                <mixed-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab>. <source>COVID-19 Mathematical Modeling</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/covid-data/mathematical-modeling.html">https://www.cdc.gov/coronavirus/2019-ncov/covid-data/mathematical-modeling.html</ext-link></comment>, <comment>Updated</comment><season>Aug.</season><day>7</day>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R4">
                <label>[4]</label>
                <mixed-citation publication-type="journal"><name><surname>Kissler</surname><given-names>Stephen M</given-names></name>, <name><surname>Tedijanto</surname><given-names>Christine</given-names></name>, <name><surname>Goldstein</surname><given-names>Edward</given-names></name>, <name><surname>Grad</surname><given-names>Yonatan H</given-names></name>, and <name><surname>Lipsitch</surname><given-names>Marc</given-names></name>. <article-title>Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period</article-title>. <source>Science</source>, <volume>368</volume>(<issue>6493</issue>):<fpage>860</fpage>–<lpage>868</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32291278</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>[5]</label>
                <mixed-citation publication-type="journal"><name><surname>Flaxman</surname><given-names>Seth</given-names></name>, <name><surname>Mishra</surname><given-names>Swapnil</given-names></name>, <name><surname>Gandy</surname><given-names>Axel</given-names></name>, <name><surname>Juliette</surname><given-names>H</given-names></name><name><surname>Unwin</surname><given-names>T</given-names></name>, <name><surname>Mellan</surname><given-names>Thomas A</given-names></name>, <name><surname>Coupland</surname><given-names>Helen</given-names></name>, <name><surname>Whittaker</surname><given-names>Charles</given-names></name>, <name><surname>Zhu</surname><given-names>Harrison</given-names></name>, <name><surname>Berah</surname><given-names>Tresnia</given-names></name>, <name><surname>Eaton</surname><given-names>Jeffrey W</given-names></name>, <name><surname>Monod</surname><given-names>Mélodie</given-names></name>, <collab>Imperial College COVID-19 Response Team</collab>, <name><surname>Ghani</surname><given-names>Azra C.</given-names></name>, <name><surname>Donnelly</surname><given-names>Christl A.</given-names></name>, <name><surname>Riley</surname><given-names>Steven</given-names></name>, <name><surname>Vollmer</surname><given-names>Michaela A. C.</given-names></name>, <name><surname>Ferguson</surname><given-names>Neil M.</given-names></name>, <name><surname>Okell</surname><given-names>Lucy C.</given-names></name>, and <name><surname>Bhatt</surname><given-names>Samir</given-names></name>. <article-title>Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe</article-title>. <source>Nature</source>, <volume>584</volume>(<issue>7820</issue>):<fpage>257</fpage>–<lpage>261</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1038/s41586-020-2405-7</pub-id><pub-id pub-id-type="pmid">32512579</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>[6]</label>
                <mixed-citation publication-type="journal"><name><surname>Salje</surname><given-names>Henrik</given-names></name>, <name><surname>Kiem</surname><given-names>Cécile Tran</given-names></name>, <name><surname>Lefrancq</surname><given-names>Noémie</given-names></name>, <name><surname>Courtejoie</surname><given-names>Noémie</given-names></name>, <name><surname>Bosetti</surname><given-names>Paolo</given-names></name>, <name><surname>Paireau</surname><given-names>Juliette</given-names></name>, <name><surname>Andronico</surname><given-names>Alessio</given-names></name>, <name><surname>Hozé</surname><given-names>Nathanaël</given-names></name>, <name><surname>Richet</surname><given-names>Jehanne</given-names></name>, <name><surname>Dubost</surname><given-names>Claire-Lise</given-names></name>, <name><surname>Strat</surname><given-names>Yann Le</given-names></name>, <name><surname>Lessler</surname><given-names>Justin</given-names></name>, <name><surname>Bruhl</surname><given-names>Daniel Levy</given-names></name>, <name><surname>Fontanet</surname><given-names>Arnaud</given-names></name>, <name><surname>Opatowski</surname><given-names>Lulla</given-names></name>, <name><surname>Boelle</surname><given-names>Pierre-Yves</given-names></name>, and <name><surname>Cauchemez</surname><given-names>Simon</given-names></name>. <article-title>Estimating the burden of SARS-CoV-2 in France</article-title>. <source>Science</source>, <volume>369</volume>(<issue>6500</issue>):<fpage>208</fpage>–<lpage>211</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32404476</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>[7]</label>
                <mixed-citation publication-type="journal"><collab>IHME COVID-19 Forecasting Team</collab>. <article-title>Modeling COVID-19 scenarios for the United States</article-title>. <source>Nature Medicine</source>, <volume>27</volume>:<fpage>94</fpage>–<lpage>105</lpage>, <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1038/s41591-020-1132-9</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>[8]</label>
                <mixed-citation publication-type="journal"><name><surname>Holmdahl</surname><given-names>Inga</given-names></name> and <name><surname>Buckee</surname><given-names>Caroline</given-names></name>. <article-title>Wrong but useful—what COVID-19 epidemiologic models can and cannot tell us</article-title>. <source>New England Journal of Medicine</source>, <volume>383</volume>(<issue>4</issue>):<fpage>303</fpage>–<lpage>305</lpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R9">
                <label>[9]</label>
                <mixed-citation publication-type="journal"><name><surname>Tanne</surname><given-names>Janice Hopkins</given-names></name>. <article-title>COVID-19: New York City deaths pass 1000 as Trump tells Americans to distance for 30 days</article-title>. <source>BMJ</source>, <volume>369</volume>:<fpage>m1333</fpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1136/bmj.m1333</pub-id><pub-id pub-id-type="pmid">32238356</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>[10]</label>
                <mixed-citation publication-type="journal"><name><surname>Uppal</surname><given-names>Amit</given-names></name>, <name><surname>Silvestri</surname><given-names>David M</given-names></name>, <name><surname>Siegler</surname><given-names>Matthew</given-names></name>, <name><surname>Natsui</surname><given-names>Shaw</given-names></name>, <name><surname>Boudourakis</surname><given-names>Leon</given-names></name>, <name><surname>Salway</surname><given-names>R James</given-names></name>, <name><surname>Parikh</surname><given-names>Manish</given-names></name>, <name><surname>Agoritsas</surname><given-names>Konstantinos</given-names></name>, <name><surname>Cho</surname><given-names>Hyung J</given-names></name>, <name><surname>Gulati</surname><given-names>Rajneesh</given-names></name>, <name><surname>Nunez</surname><given-names>Milton</given-names></name>, <name><surname>Hulbanni</surname><given-names>Anjali</given-names></name>, <name><surname>Flaherty</surname><given-names>Christine</given-names></name>, <name><surname>Iavicoli</surname><given-names>Laura</given-names></name>, <name><surname>Cineas</surname><given-names>Natalia</given-names></name>, <name><surname>Kanter</surname><given-names>Marc</given-names></name>, <name><surname>Kessler</surname><given-names>Stuart</given-names></name>, <name><surname>Rhodes</surname><given-names>Karin V.</given-names></name>, <name><surname>Bouton</surname><given-names>Michael</given-names></name>, and <name><surname>Wei</surname><given-names>Eric K.</given-names></name>. <article-title>Critical care and emergency department response at the epicenter of the COVID-19 pandemic</article-title>. <source>Health Affairs</source>, <volume>39</volume>(<issue>8</issue>):<fpage>1443</fpage>–<lpage>1449</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1377/hlthaff.2020.00901</pub-id><pub-id pub-id-type="pmid">32525713</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>[11]</label>
                <mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>Corinne N</given-names></name>, <name><surname>Baumgartner</surname><given-names>Jennifer</given-names></name>, <name><surname>Pichardo</surname><given-names>Carolina</given-names></name>, <name><surname>Toro</surname><given-names>Brian</given-names></name>, <name><surname>Li</surname><given-names>Lan</given-names></name>, <name><surname>Arciuolo</surname><given-names>Robert</given-names></name>, <name><surname>Chan</surname><given-names>Pui Ying</given-names></name>, <name><surname>Chen</surname><given-names>Judy</given-names></name>, <name><surname>Culp</surname><given-names>Gretchen</given-names></name>, <name><surname>Davidson</surname><given-names>Alexander</given-names></name>, <etal/><article-title>COVID-19 outbreak —- New York City, February 29–June 1, 2020</article-title>. <source>Morbidity and Mortality Weekly Report</source>, <volume>69</volume>(<issue>46</issue>):<fpage>1725</fpage>–<lpage>1729</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">33211680</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>[12]</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Qun</given-names></name>, <name><surname>Guan</surname><given-names>Xuhua</given-names></name>, <name><surname>Wu</surname><given-names>Peng</given-names></name>, <name><surname>Wang</surname><given-names>Xiaoye</given-names></name>, <name><surname>Zhou</surname><given-names>Lei</given-names></name>, <name><surname>Tong</surname><given-names>Yeqing</given-names></name>, <name><surname>Ren</surname><given-names>Ruiqi</given-names></name>, <name><surname>Leung</surname><given-names>Kathy S.M.</given-names></name>, <name><surname>Lau</surname><given-names>Eric H.Y.</given-names></name>, <name><surname>Wong</surname><given-names>Jessica Y.</given-names></name>, <name><surname>Xing</surname><given-names>Xuesen</given-names></name>, <name><surname>Xiang</surname><given-names>Nijuan</given-names></name>, <name><surname>Wu</surname><given-names>Yang</given-names></name>, <name><surname>Li</surname><given-names>Chao</given-names></name>, <name><surname>Chen</surname><given-names>Qi</given-names></name>, <name><surname>Li</surname><given-names>Dan</given-names></name>, <name><surname>Liu</surname><given-names>Tian</given-names></name>, <name><surname>Zhao</surname><given-names>Jing</given-names></name>, <name><surname>Liu</surname><given-names>Man</given-names></name>, <name><surname>Tu</surname><given-names>Wenxiao</given-names></name>, <name><surname>Chen</surname><given-names>Chuding</given-names></name>, <name><surname>Jin</surname><given-names>Lianmei</given-names></name>, <name><surname>Yang</surname><given-names>Rui</given-names></name>, <name><surname>Wang</surname><given-names>Qi</given-names></name>, <name><surname>Zhou</surname><given-names>Suhua</given-names></name>, <name><surname>Wang</surname><given-names>Rui</given-names></name>, <name><surname>Liu</surname><given-names>Hui</given-names></name>, <name><surname>Luo</surname><given-names>Yinbo</given-names></name>, <name><surname>Liu</surname><given-names>Yuan</given-names></name>, <name><surname>Shao</surname><given-names>Ge</given-names></name>, <name><surname>Li</surname><given-names>Huan</given-names></name>, <name><surname>Tao</surname><given-names>Zhongfa</given-names></name>, <name><surname>Yang</surname><given-names>Yang</given-names></name>, <name><surname>Deng</surname><given-names>Zhiqiang</given-names></name>, <name><surname>Liu</surname><given-names>Boxi</given-names></name>, <name><surname>Ma</surname><given-names>Zhitao</given-names></name>, <name><surname>Zhang</surname><given-names>Yanping</given-names></name>, <name><surname>Shi</surname><given-names>Guoqing</given-names></name>, <name><surname>Lam</surname><given-names>Tommy T.Y.</given-names></name>, <name><surname>Wu</surname><given-names>Joseph T.</given-names></name>, <name><surname>Gao</surname><given-names>George F.</given-names></name>, <name><surname>Cowling</surname><given-names>Benjamin J.</given-names></name>, <name><surname>Yang</surname><given-names>Bo</given-names></name>, <name><surname>Leung</surname><given-names>Gabriel M.</given-names></name>, and <name><surname>Feng</surname><given-names>Zijian</given-names></name>. <article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia</article-title>. <source>New England Journal of Medicine</source>, <volume>382</volume>(<issue>13</issue>):<fpage>1199</fpage>–<lpage>1207</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>[13]</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Joseph T</given-names></name>, <name><surname>Leung</surname><given-names>Kathy</given-names></name>, and <name><surname>Leung</surname><given-names>Gabriel M</given-names></name>. <article-title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</article-title>. <source>The Lancet</source>, <volume>395</volume>(<issue>10225</issue>):<fpage>689</fpage>–<lpage>697</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30260-9</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>[14]</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Joseph T</given-names></name>, <name><surname>Leung</surname><given-names>Kathy</given-names></name>, <name><surname>Bushman</surname><given-names>Mary</given-names></name>, <name><surname>Kishore</surname><given-names>Nishant</given-names></name>, <name><surname>Niehus</surname><given-names>Rene</given-names></name>, <name><surname>de Salazar</surname><given-names>Pablo M</given-names></name>, <name><surname>Cowling</surname><given-names>Benjamin J</given-names></name>, <name><surname>Lipsitch</surname><given-names>Marc</given-names></name>, and <name><surname>Leung</surname><given-names>Gabriel M</given-names></name>. <article-title>Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China</article-title>. <source>Nature Medicine</source>, <volume>26</volume>(<issue>4</issue>):<fpage>506</fpage>–<lpage>510</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1038/s41591-020-0822-7</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>[15]</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Ruiyun</given-names></name>, <name><surname>Pei</surname><given-names>Sen</given-names></name>, <name><surname>Chen</surname><given-names>Bin</given-names></name>, <name><surname>Song</surname><given-names>Yimeng</given-names></name>, <name><surname>Zhang</surname><given-names>Tao</given-names></name>, <name><surname>Yang</surname><given-names>Wan</given-names></name>, and <name><surname>Shaman</surname><given-names>Jeffrey</given-names></name>. <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)</article-title>. <source>Science</source>, <volume>368</volume> (<issue>6490</issue>):<fpage>489</fpage>–<lpage>493</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1126/science.abb3221</pub-id><pub-id pub-id-type="pmid">32179701</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>[16]</label>
                <mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>Huaiyu</given-names></name>, <name><surname>Liu</surname><given-names>Yonghong</given-names></name>, <name><surname>Li</surname><given-names>Yidan</given-names></name>, <name><surname>Wu</surname><given-names>Chieh-Hsi</given-names></name>, <name><surname>Chen</surname><given-names>Bin</given-names></name>, <name><surname>Kraemer</surname><given-names>Moritz U. G.</given-names></name>, <name><surname>Li</surname><given-names>Bingying</given-names></name>, <name><surname>Cai</surname><given-names>Jun</given-names></name>, <name><surname>Xu</surname><given-names>Bo</given-names></name>, <name><surname>Yang</surname><given-names>Qiqi</given-names></name>, <name><surname>Wang</surname><given-names>Ben</given-names></name>, <name><surname>Yang</surname><given-names>Peng</given-names></name>, <name><surname>Cui</surname><given-names>Yujun</given-names></name>, <name><surname>Song</surname><given-names>Yimeng</given-names></name>, <name><surname>Zheng</surname><given-names>Pai</given-names></name>, <name><surname>Wang</surname><given-names>Quanyi</given-names></name>, <name><surname>Bjornstad</surname><given-names>Ottar N.</given-names></name>, <name><surname>Yang</surname><given-names>Ruifu</given-names></name>, <name><surname>Grenfell</surname><given-names>Bryan T.</given-names></name>, <name><surname>Pybus</surname><given-names>Oliver G.</given-names></name>, and <name><surname>Dye</surname><given-names>Christopher</given-names></name>. <article-title>An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China</article-title>. <source>Science</source>, <volume>368</volume> (<issue>6491</issue>):<fpage>638</fpage>–<lpage>642</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1126/science.abb6105</pub-id><pub-id pub-id-type="pmid">32234804</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>[17]</label>
                <mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>Adam J</given-names></name>, <name><surname>Russell</surname><given-names>Timothy W</given-names></name>, <name><surname>Diamond</surname><given-names>Charlie</given-names></name>, <name><surname>Liu</surname><given-names>Yang</given-names></name>, <name><surname>Edmunds</surname><given-names>John</given-names></name>, <name><surname>Funk</surname><given-names>Sebastian</given-names></name>, <name><surname>Eggo</surname><given-names>Rosalind M</given-names></name>, and <collab>Centre for Mathematical Modelling of Infectious Diseases COVID-19 working group</collab>. <article-title>Early dynamics of transmission and control of COVID-19: a mathematical modelling study</article-title>. <source>The Lancet Infectious Diseases</source>, <volume>20</volume>(<issue>5</issue>):<fpage>553</fpage>–<lpage>558</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30144-4</pub-id><pub-id pub-id-type="pmid">32171059</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>[18]</label>
                <mixed-citation publication-type="journal"><name><surname>Leung</surname><given-names>Kathy</given-names></name>, <name><surname>Wu</surname><given-names>Joseph T</given-names></name>, <name><surname>Liu</surname><given-names>Di</given-names></name>, and <name><surname>Leung</surname><given-names>Gabriel M</given-names></name>. <article-title>First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment</article-title>. <source>The Lancet</source>, <volume>395</volume>(<issue>10233</issue>):<fpage>1382</fpage>–<lpage>1393</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30746-7</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>[19]</label>
                <mixed-citation publication-type="journal"><name><surname>Hauser</surname><given-names>Anthony</given-names></name>, <name><surname>Counotte</surname><given-names>Michel J</given-names></name>, <name><surname>Margossian</surname><given-names>Charles C</given-names></name>, <name><surname>Konstantinoudis</surname><given-names>Garyfallos</given-names></name>, <name><surname>Low</surname><given-names>Nicola</given-names></name>, <name><surname>Althaus</surname><given-names>Christian L</given-names></name>, and <name><surname>Riou</surname><given-names>Julien</given-names></name>. <article-title>Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe</article-title>. <source>PLoS Medicine</source>, <volume>17</volume>(<issue>7</issue>):<fpage>e1003189</fpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.1003189</pub-id><pub-id pub-id-type="pmid">32722715</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>[20]</label>
                <mixed-citation publication-type="journal"><name><surname>Dehning</surname><given-names>Jonas</given-names></name>, <name><surname>Zierenberg</surname><given-names>Johannes</given-names></name>, <name><surname>Spitzner</surname><given-names>F Paul</given-names></name>, <name><surname>Wibral</surname><given-names>Michael</given-names></name>, <name><surname>Neto</surname><given-names>Joao Pinheiro</given-names></name>, <name><surname>Wilczek</surname><given-names>Michael</given-names></name>, and <name><surname>Priesemann</surname><given-names>Viola</given-names></name>. <article-title>Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions</article-title>. <source>Science</source>, <volume>369</volume>(<issue>6500</issue>):<fpage>eabb9789</fpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1126/science.abb9789</pub-id><pub-id pub-id-type="pmid">32414780</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>[21]</label>
                <mixed-citation publication-type="journal"><name><surname>Prem</surname><given-names>Kiesha</given-names></name>, <name><surname>Liu</surname><given-names>Yang</given-names></name>, <name><surname>Russell</surname><given-names>Timothy W</given-names></name>, <name><surname>Kucharski</surname><given-names>Adam J</given-names></name>, <name><surname>Eggo</surname><given-names>Rosalind M</given-names></name>, <name><surname>Davies</surname><given-names>Nicholas</given-names></name>, <collab>Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group</collab>, <name><surname>Jit</surname><given-names>Mark</given-names></name>, and <name><surname>Klepac</surname><given-names>Petra</given-names></name>. <article-title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study</article-title>. <source>The Lancet Public Health</source>, <volume>5</volume>:<fpage>e261</fpage>–<lpage>e270</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30073-6</pub-id><pub-id pub-id-type="pmid">32220655</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <label>[22]</label>
                <mixed-citation publication-type="journal"><name><surname>Juliette</surname><given-names>H.</given-names></name><name><surname>Unwin</surname><given-names>T.</given-names></name>, <name><surname>Mishra</surname><given-names>Swapnil</given-names></name>, <name><surname>Bradley</surname><given-names>Valerie C.</given-names></name>, <name><surname>Gandy</surname><given-names>Axel</given-names></name>, <name><surname>Mellan</surname><given-names>Thomas A.</given-names></name>, <name><surname>Coupland</surname><given-names>Helen</given-names></name>, <name><surname>Ish-Horowicz</surname><given-names>Jonathan</given-names></name>, <name><surname>Vollmer</surname><given-names>Michaela A. C.</given-names></name>, <name><surname>Whittaker</surname><given-names>Charles</given-names></name>, <name><surname>Filippi</surname><given-names>Sarah L.</given-names></name>, <name><surname>Xi</surname><given-names>Xiaoyue</given-names></name>, <name><surname>Monod</surname><given-names>Meelodie</given-names></name>, <name><surname>Ratmann</surname><given-names>Oliver</given-names></name>, <name><surname>Hutchinson</surname><given-names>Michael</given-names></name>, <name><surname>Valka</surname><given-names>Fabian</given-names></name>, <name><surname>Zhu</surname><given-names>Harrison</given-names></name>, <name><surname>Hawryluk</surname><given-names>Iwona</given-names></name>, <name><surname>Milton</surname><given-names>Philip</given-names></name>, <name><surname>Ainslie</surname><given-names>Kylie E. C.</given-names></name>, <name><surname>Baguelin</surname><given-names>Marc</given-names></name>, <name><surname>Boonyasiri</surname><given-names>Adhiratha</given-names></name>, <name><surname>Brazeau</surname><given-names>Nick F.</given-names></name>, <name><surname>Cattarino</surname><given-names>Lorenzo</given-names></name>, <name><surname>Cucunuba</surname><given-names>Zulma</given-names></name>, <name><surname>Cuomo-Dannenburg</surname><given-names>Gina</given-names></name>, <name><surname>Dorigatti</surname><given-names>Ilaria</given-names></name>, <name><surname>Eales</surname><given-names>Oliver D.</given-names></name>, <name><surname>Eaton</surname><given-names>Jeffrey W.</given-names></name>, <name><surname>van Elsland</surname><given-names>Sabine L.</given-names></name>, <name><surname>FitzJohn</surname><given-names>Richard G.</given-names></name>, <name><surname>Gaythorpe</surname><given-names>Katy A. M.</given-names></name>, <name><surname>Green</surname><given-names>William</given-names></name>, <name><surname>Hinsley</surname><given-names>Wes</given-names></name>, <name><surname>Jeffrey</surname><given-names>Benjamin</given-names></name>, <name><surname>Knock</surname><given-names>Edward</given-names></name>, <name><surname>Laydon</surname><given-names>Daniel J.</given-names></name>, <name><surname>Lees</surname><given-names>John</given-names></name>, <name><surname>Nedjati-Gilani</surname><given-names>Gemma</given-names></name>, <name><surname>Nouvellet</surname><given-names>Pierre</given-names></name>, <name><surname>Okell</surname><given-names>Lucy</given-names></name>, <name><surname>Parag</surname><given-names>Kris V.</given-names></name>, <name><surname>Siveroni</surname><given-names>Igor</given-names></name>, <name><surname>Thompson</surname><given-names>Hayley A.</given-names></name>, <name><surname>Walker</surname><given-names>Patrick</given-names></name>, <name><surname>Walters</surname><given-names>Caroline E.</given-names></name>, <name><surname>Watson</surname><given-names>Oliver J.</given-names></name>, <name><surname>Whittles</surname><given-names>Lilith K.</given-names></name>, <name><surname>Ghani</surname><given-names>Azra C.</given-names></name><comment>1</comment>, <name><surname>Ferguson</surname><given-names>Neil M.</given-names></name>, <name><surname>Riley</surname><given-names>Steven</given-names></name>, <name><surname>Donnelly</surname><given-names>Christl A.</given-names></name>, <name><surname>Bhatt</surname><given-names>Samir</given-names></name>, and <name><surname>Flaxman</surname><given-names>Seth</given-names></name>. <article-title>State-level tracking of COVID-19 in the United States</article-title>. <source>Nature Communications</source>, <volume>11</volume>(<issue>6189</issue>):<fpage>1</fpage>–<lpage>9</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-19652-6</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>[23]</label>
                <mixed-citation publication-type="journal"><name><surname>Aleta</surname><given-names>Alberto</given-names></name>, <name><surname>Martin-Corral</surname><given-names>David</given-names></name>, <name><surname>Piontti</surname><given-names>Ana Pastore y</given-names></name>, <name><surname>Ajelli</surname><given-names>Marco</given-names></name>, <name><surname>Litvinova</surname><given-names>Maria</given-names></name>, <name><surname>Chinazzi</surname><given-names>Matteo</given-names></name>, <name><surname>Dean</surname><given-names>Natalie E</given-names></name>, <name><surname>Halloran</surname><given-names>M Elizabeth</given-names></name>, <name><surname>Longini</surname><given-names>Ira M</given-names><suffix>Jr</suffix></name>, <name><surname>Merler</surname><given-names>Stefano</given-names></name>, <name><surname>Pentland</surname><given-names>Alex</given-names></name>, <name><surname>Vespignani</surname><given-names>Alessandro</given-names></name>, <name><surname>Moro</surname><given-names>Esteban</given-names></name>, and <name><surname>Moreno</surname><given-names>Yamir</given-names></name>. <article-title>Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19</article-title>. <source>Nature Human Behaviour</source>, <volume>4</volume>(<issue>9</issue>):<fpage>964</fpage>–<lpage>971</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1038/s41562-020-0931-9</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>[24]</label>
                <mixed-citation publication-type="journal"><name><surname>Fintzi</surname><given-names>Jonathan</given-names></name>, <name><surname>Bayer</surname><given-names>Damon</given-names></name>, <name><surname>Goldstein</surname><given-names>Isaac</given-names></name>, <name><surname>Lumbard</surname><given-names>Keith</given-names></name>, <name><surname>Ricotta</surname><given-names>Emily</given-names></name>, <name><surname>Warner</surname><given-names>Sarah</given-names></name>, <name><surname>Busch</surname><given-names>Lindsay M</given-names></name>, <name><surname>Strich</surname><given-names>Jeffrey R</given-names></name>, <name><surname>Chertow</surname><given-names>Daniel S</given-names></name>, <name><surname>Parker</surname><given-names>Daniel M</given-names></name>, <name><surname>Boden-Albala</surname><given-names>Bernadette</given-names></name>, <name><surname>Dratch</surname><given-names>Alissa</given-names></name>, <name><surname>Chhuon</surname><given-names>Richard</given-names></name>, <name><surname>Quick</surname><given-names>Nichole</given-names></name>, <name><surname>Zahn</surname><given-names>Matthew</given-names></name>, and <name><surname>Minin</surname><given-names>Vladimir N</given-names></name>. <article-title>Using multiple data streams to estimate and forecast SARS-CoV-2 transmission dynamics, with application to the virus spread in Orange County, California</article-title>. <source>arXiv</source><comment>preprint arXiv:2009.02654</comment>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/2009.02654">https://arxiv.org/abs/2009.02654</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R25">
                <label>[25]</label>
                <mixed-citation publication-type="journal"><name><surname>Bracis</surname><given-names>Chloe</given-names></name>, <name><surname>Burns</surname><given-names>Eileen</given-names></name>, <name><surname>Moore</surname><given-names>Mia</given-names></name>, <name><surname>Swan</surname><given-names>David</given-names></name>, <name><surname>Reeves</surname><given-names>Daniel B</given-names></name>, <name><surname>Schiffer</surname><given-names>Joshua T</given-names></name>, and <name><surname>Dimitrov</surname><given-names>Dobromir</given-names></name>. <article-title>Widespread testing, case isolation and contact tracing may allow safe school reopening with continued moderate physical distancing: A modeling analysis of King County, WA data</article-title>. <source>Infectious Disease Modelling</source>, <volume>6</volume>:<fpage>24</fpage>–<lpage>35</lpage>, <year>2021</year>.<pub-id pub-id-type="pmid">33294745</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>[26]</label>
                <mixed-citation publication-type="journal"><name><surname>Tran</surname><given-names>Thu Nguyen-Anh</given-names></name>, <name><surname>Wikle</surname><given-names>Nathan</given-names></name>, <name><surname>Albert</surname><given-names>Joseph</given-names></name>, <name><surname>Inam</surname><given-names>Haider</given-names></name>, <name><surname>Emily R Strong</surname><given-names>Karel Brinda</given-names></name>, <name><surname>Leighow</surname><given-names>Scott M</given-names></name>, <name><surname>Yang</surname><given-names>Fuhan</given-names></name>, <name><surname>Hossain</surname><given-names>Sajid</given-names></name>, <name><surname>Pritchard</surname><given-names>Justin R</given-names></name>, <name><surname>Chan</surname><given-names>Philip</given-names></name>, <name><surname>Hanage</surname><given-names>William P</given-names></name>, <name><surname>Hanks</surname><given-names>Ephraim M</given-names></name>, and <name><surname>Boni</surname><given-names>Maciej F</given-names></name>. <article-title>Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts</article-title>. <source>medRxiv</source>, <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1101/2021.01.12.21249694</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2021.01.12.21249694v1">https://www.medrxiv.org/content/10.1101/2021.01.12.21249694v1</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R27">
                <label>[27]</label>
                <mixed-citation publication-type="journal"><name><surname>Crawford</surname><given-names>Forrest W.</given-names></name>, <name><surname>Li</surname><given-names>Zehang Richard</given-names></name>, and <name><surname>Morozova</surname><given-names>Olga</given-names></name>. <article-title>COVID-19 projections for reopening Connecticut</article-title>. <source>medRxiv</source>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1101/2020.06.16.20126425</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/early/2020/06/19/2020.06.16.20126425">https://www.medrxiv.org/content/early/2020/06/19/2020.06.16.20126425</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R28">
                <label>[28]</label>
                <mixed-citation publication-type="journal"><name><surname>Peccia</surname><given-names>Jordan</given-names></name>, <name><surname>Zulli</surname><given-names>Alessandro</given-names></name>, <name><surname>Brackney</surname><given-names>Doug E</given-names></name>, <name><surname>Grubaugh</surname><given-names>Nathan D</given-names></name>, <name><surname>Kaplan</surname><given-names>Edward H</given-names></name>, <name><surname>Casanovas-Massana</surname><given-names>Arnau</given-names></name>, <name><surname>Ko</surname><given-names>Albert I</given-names></name>, <name><surname>Malik</surname><given-names>Amyn A</given-names></name>, <name><surname>Wang</surname><given-names>Dennis</given-names></name>, <name><surname>Wang</surname><given-names>Mike</given-names></name>, <name><surname>Warren</surname><given-names>Joshua L</given-names></name>, <name><surname>Weinberger</surname><given-names>Daniel M</given-names></name>, <name><surname>Arnold</surname><given-names>Wyatt</given-names></name>, and <name><surname>Omer</surname><given-names>Saad B</given-names></name>. <article-title>Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics</article-title>. <source>Nature Biotechnology</source>, <volume>38</volume>(<issue>10</issue>):<fpage>1164</fpage>–<lpage>1167</lpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R29">
                <label>[29]</label>
                <mixed-citation publication-type="web"><collab>State of Connecticut Office of Policy and Management</collab>. <source>Connecticut Open Data: COVID-19 Data Resources</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://data.ct.gov/stories/s/COVID-19-data/wa3g-tfvc/">https://data.ct.gov/stories/s/COVID-19-data/wa3g-tfvc/</ext-link>.</comment><comment>Accessed</comment>: <date-in-citation>2021-03-29</date-in-citation>.</mixed-citation>
              </ref>
              <ref id="R30">
                <label>[30]</label>
                <mixed-citation publication-type="web"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Executive Order No. 7C: Protection of public health and safety during COVID-19 pandemic and response – further suspension or modification of statutes</source>, <month>3</month><year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7C.pdf">https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7C.pdf</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R31">
                <label>[31]</label>
                <mixed-citation publication-type="web"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Executive Order No. 7L: Protection of public health and safety during COVID-19 pandemic and response - extension of school cancellation, municipal retiree reemployment, open fishing season and additional public health measures</source>, <month>3</month><year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7L.pdf">https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7L.pdf</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R32">
                <label>[32]</label>
                <mixed-citation publication-type="web"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Executive Order No. 7X: Protection of public health and safety during COVID-19 pandemic and response – renter protections, extended class cancellation and other safety measures, educator certification, food trucks for truckers</source>, <month>4</month><year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7X.pdf">https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7X.pdf</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R33">
                <label>[33]</label>
                <mixed-citation publication-type="web"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Executive Order No 7II: Protection of public health and safety during COVID-19 pandemic and response – extension of school cancellation, home health care coverage, and food assistance measures</source>, <month>5</month><year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7II.pdf">https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7II.pdf</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R34">
                <label>[34]</label>
                <mixed-citation publication-type="web"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Executive Order No. 7H: Protection of public health and safety during COVID-19 pandemic and response - restrictions on workplaces for non-essential businesses, coordinated response effort</source>, <month>3</month><year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7H.pdf">https://portal.ct.gov/-/media/Office-of-the-Governor/Executive-Orders/Lamont-Executive-Orders/Executive-Order-No-7H.pdf</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R35">
                <label>[35]</label>
                <mixed-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab>. <source>COVID Data Tracker: Explore human mobility and COVID-19 transmission in your local area</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://covid.cdc.gov/covid-data-tracker/#mobility">https://covid.cdc.gov/covid-data-tracker/#mobility</ext-link></comment>. <comment>Accessed</comment>: <date-in-citation>2021-03-29</date-in-citation></mixed-citation>
              </ref>
              <ref id="R36">
                <label>[36]</label>
                <mixed-citation publication-type="book"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Governor Lamont releases rules for businesses under First Phase of Connecticut’s reopening plans amid COVID-19</source>. <publisher-name>State of Connecticut Press Release</publisher-name>, <month>5</month><day>9</day>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/05-2020/Governor-Lamont-Releases-Rules-for-Businesses-Under-First-Phase-of-Reopening-Plans">https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/05-2020/Governor-Lamont-Releases-Rules-for-Businesses-Under-First-Phase-of-Reopening-Plans</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R37">
                <label>[37]</label>
                <mixed-citation publication-type="book"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Governor Lamont releases business documents for Phase 2 reopening on June 17</source>. <publisher-name>State of Connecticut Press Release</publisher-name>, <month>6</month><day>7</day>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/06-2020/Governor-Lamont-Releases-Business-Documents-for-Phase-2-Reopening-on-June-17">https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/06-2020/Governor-Lamont-Releases-Business-Documents-for-Phase-2-Reopening-on-June-17</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R38">
                <label>[38]</label>
                <mixed-citation publication-type="book"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Governor Lamont announces Connecticut moves toward Phase 3 reopening on October 8</source>. <publisher-name>State of Connecticut Press Release</publisher-name>, <month>9</month><day>24</day>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/09-2020/Governor-Lamont-Announces-Connecticut-Moves-Toward-Phase-3-Reopening-on-October-8">https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/09-2020/Governor-Lamont-Announces-Connecticut-Moves-Toward-Phase-3-Reopening-on-October-8</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R39">
                <label>[39]</label>
                <mixed-citation publication-type="book"><name><surname>Lamont</surname><given-names>Ned</given-names></name>. <source>Governor Lamont provides update on Connecticut’s coronavirus response efforts</source>. <publisher-name>State of Connecticut Press Release</publisher-name>, <month>11</month><day>2</day>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/11-2020/Governor-Lamont-Coronavirus-Update-November-2">https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2020/11-2020/Governor-Lamont-Coronavirus-Update-November-2</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R40">
                <label>[40]</label>
                <mixed-citation publication-type="web"><collab>United States Census Bureau</collab>. <source>American Community Survey (ACS)</source>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.census.gov/programs-surveys/acs">https://www.census.gov/programs-surveys/acs</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R41">
                <label>[41]</label>
                <mixed-citation publication-type="web"><source>Connecticut Hospital Association</source>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://cthosp.org/">https://cthosp.org/</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R42">
                <label>[42]</label>
                <mixed-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab>. <source>Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html">https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html</ext-link></comment>, <comment>Updated</comment><season>Oct.</season><day>5</day>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R43">
                <label>[43]</label>
                <mixed-citation publication-type="journal"><name><surname>Crawford</surname><given-names>Forrest W.</given-names></name>, <name><surname>Jones</surname><given-names>Sydney</given-names></name>, <name><surname>Cartter</surname><given-names>Matthew</given-names></name>, <name><surname>Dean</surname><given-names>Samantha G.</given-names></name>, <name><surname>Warren</surname><given-names>Joshua L.</given-names></name>, <name><surname>Li</surname><given-names>Zehang Richard</given-names></name>, <name><surname>Barbieri</surname><given-names>Jacqueline</given-names></name>, <name><surname>Campbell</surname><given-names>Jared</given-names></name>, <name><surname>Kenney</surname><given-names>Patrick</given-names></name>, <name><surname>Valleau</surname><given-names>Thomas</given-names></name>, and <name><surname>Morozova</surname><given-names>Olga</given-names></name>. <article-title>Impact of close interpersonal contact on COVID-19 incidence: evidence from one year of mobile device data</article-title>. <source>medRxiv</source>, <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1101/2021.03.10.21253282</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2021.03.10.21253282v1">https://www.medrxiv.org/content/10.1101/2021.03.10.21253282v1</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R44">
                <label>[44]</label>
                <mixed-citation publication-type="book"><name><surname>Keeling</surname><given-names>Matt J</given-names></name> and <name><surname>Rohani</surname><given-names>Pejman</given-names></name>. <source>Modeling infectious diseases in humans and animals</source>. <publisher-name>Princeton University Press</publisher-name>, <year>2011</year>.</mixed-citation>
              </ref>
              <ref id="R45">
                <label>[45]</label>
                <mixed-citation publication-type="web"><collab>United States Census Bureau</collab>. <source>2010 cartographic boundary file, current block group for Connecticut</source>. <comment>Data retrieved from <ext-link ext-link-type="uri" xlink:href="http://magic.lib.uconn.edu/connecticut_data.html">http://magic.lib.uconn.edu/connecticut_data.html</ext-link></comment>, <year>2010</year>. <comment>Accessed</comment>: <date-in-citation>2020-04-14</date-in-citation>.</mixed-citation>
              </ref>
              <ref id="R46">
                <label>[46]</label>
                <mixed-citation publication-type="book"><collab>R Core Team</collab>. <source>R: A Language and Environment for Statistical Computing</source>. <publisher-name>R Foundation for Statistical Computing</publisher-name>, <publisher-loc>Vienna, Austria</publisher-loc>, <year>2020</year>. URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R47">
                <label>[47]</label>
                <mixed-citation publication-type="journal"><name><surname>Soetaert</surname><given-names>Karline</given-names></name>, <name><surname>Petzoldt</surname><given-names>Thomas</given-names></name>, and <name><surname>Setzer</surname><given-names>R. Woodrow</given-names></name>. <article-title>Solving differential equations in R: Package deSolve</article-title>. <source>Journal of Statistical Software</source>, <volume>33</volume>(<issue>9</issue>):<fpage>1</fpage>–<lpage>25</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20808728</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <label>[48]</label>
                <mixed-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab>. <source>COVID-19: When you’ve been fully vaccinated</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html</ext-link></comment>, <comment>Updated</comment>: <year>2021</year>-<month>4</month>-<day>02</day>. <comment>Accessed</comment>: <date-in-citation>2021-04-05</date-in-citation>.</mixed-citation>
              </ref>
              <ref id="R49">
                <label>[49]</label>
                <mixed-citation publication-type="journal"><name><surname>Verity</surname><given-names>Robert</given-names></name>, <name><surname>Okell</surname><given-names>Lucy C</given-names></name>, <name><surname>Dorigatti</surname><given-names>Ilaria</given-names></name>, <name><surname>Winskill</surname><given-names>Peter</given-names></name>, <name><surname>Whittaker</surname><given-names>Charles</given-names></name>, <name><surname>Imai</surname><given-names>Natsuko</given-names></name>, <name><surname>Cuomo-Dannenburg</surname><given-names>Gina</given-names></name>, <name><surname>Thompson</surname><given-names>Hayley</given-names></name>, <name><surname>Walker</surname><given-names>Patrick GT</given-names></name>, <name><surname>Fu</surname><given-names>Han</given-names></name>, <name><surname>Dighe</surname><given-names>Amy</given-names></name>, <name><surname>Griffin</surname><given-names>Jamie T</given-names></name>, <name><surname>Baguelin</surname><given-names>Marc</given-names></name>, <name><surname>Bhatia</surname><given-names>Sangeeta</given-names></name>, <name><surname>Boonyasiri</surname><given-names>Anne</given-names></name>, <name><surname>Cori</surname><given-names>Adhiratha andd</given-names></name>, <name><surname>Cucunubá</surname><given-names>Zulma</given-names></name>, <name><surname>FitzJohn</surname><given-names>Rich</given-names></name>, <name><surname>Gaythorpe</surname><given-names>Katy</given-names></name>, <name><surname>Green</surname><given-names>Will</given-names></name>, <name><surname>Hamlet</surname><given-names>Arran</given-names></name>, <name><surname>Hinsley</surname><given-names>Wes</given-names></name>, <name><surname>Laydon</surname><given-names>Daniel</given-names></name>, <name><surname>Nedjati-Gilani</surname><given-names>Gemma</given-names></name>, <name><surname>Riley</surname><given-names>Steven</given-names></name>, <name><surname>van Elsland</surname><given-names>Sabine</given-names></name>, <name><surname>Volz</surname><given-names>Erik</given-names></name>, <name><surname>Wang</surname><given-names>Haowei</given-names></name>, <name><surname>Wang</surname><given-names>Yuanrong</given-names></name>, <name><surname>Xi</surname><given-names>Xiaoyue</given-names></name>, <name><surname>Donnelly</surname><given-names>Christl A</given-names></name>, <name><surname>Ghani</surname><given-names>Azra C</given-names></name>, and <name><surname>Ferguson</surname><given-names>Neil M</given-names></name>. <article-title>Estimates of the severity of coronavirus disease 2019: a model-based analysis</article-title>. <source>The Lancet Infectious Diseases</source>, <volume>20</volume>(<issue>6</issue>):<fpage>669</fpage>–<lpage>677</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30243-7</pub-id><pub-id pub-id-type="pmid">32240634</pub-id></mixed-citation>
              </ref>
              <ref id="R50">
                <label>[50]</label>
                <mixed-citation publication-type="journal"><name><surname>Boehmer</surname><given-names>Tegan K</given-names></name>, <name><surname>DeVies</surname><given-names>Jourdan</given-names></name>, <name><surname>Caruso</surname><given-names>Elise</given-names></name>, <name><surname>van Santen</surname><given-names>Katharina L</given-names></name>, <name><surname>Tang</surname><given-names>Shichao</given-names></name>, <name><surname>Black</surname><given-names>Carla L</given-names></name>, <name><surname>Hartnett</surname><given-names>Kathleen P</given-names></name>, <name><surname>Kite-Powell</surname><given-names>Aaron</given-names></name>, <name><surname>Dietz</surname><given-names>Stephanie</given-names></name>, <name><surname>Lozier</surname><given-names>Matthew</given-names></name>, and <name><surname>Gundlapalli</surname><given-names>Adi V</given-names></name>. <article-title>Changing age distribution of the COVID-19 pandemic — United States, May–August 2020</article-title>. <source>Morbidity and Mortality Weekly Report</source>, <volume>69</volume>(<issue>39</issue>):<fpage>1404</fpage>–<lpage>1409</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">33001872</pub-id></mixed-citation>
              </ref>
              <ref id="R51">
                <label>[51]</label>
                <mixed-citation publication-type="journal"><name><surname>Katul</surname><given-names>Gabriel G</given-names></name>, <name><surname>Mrad</surname><given-names>Assaad</given-names></name>, <name><surname>Bonetti</surname><given-names>Sara</given-names></name>, <name><surname>Manoli</surname><given-names>Gabriele</given-names></name>, and <name><surname>Parolari</surname><given-names>Anthony J</given-names></name>. <article-title>Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics</article-title>. <source>PLoS ONE</source>, <volume>15</volume>(<issue>9</issue>): <fpage>e0239800</fpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32970786</pub-id></mixed-citation>
              </ref>
              <ref id="R52">
                <label>[52]</label>
                <mixed-citation publication-type="journal"><name><surname>Sanche</surname><given-names>Steven</given-names></name>, <name><surname>Lin</surname><given-names>Yen Ting</given-names></name>, <name><surname>Xu</surname><given-names>Chonggang</given-names></name>, <name><surname>Romero-Severson</surname><given-names>Ethan</given-names></name>, <name><surname>Hengartner</surname><given-names>Nick</given-names></name>, and <name><surname>Ke</surname><given-names>Ruian</given-names></name>. <article-title>High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2</article-title>. <source>Emerging Infectious Diseases</source>, <volume>26</volume>(<issue>7</issue>):<fpage>1470</fpage>–<lpage>1477</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32255761</pub-id></mixed-citation>
              </ref>
              <ref id="R53">
                <label>[53]</label>
                <mixed-citation publication-type="journal"><name><surname>Havers</surname><given-names>Fiona P</given-names></name>, <name><surname>Reed</surname><given-names>Carrie</given-names></name>, <name><surname>Lim</surname><given-names>Travis</given-names></name>, <name><surname>Montgomery</surname><given-names>Joel M</given-names></name>, <name><surname>Klena</surname><given-names>John D</given-names></name>, <name><surname>Hall</surname><given-names>Aron J</given-names></name>, <name><surname>Fry</surname><given-names>Alicia M</given-names></name>, <name><surname>Cannon</surname><given-names>Deborah L</given-names></name>, <name><surname>Chiang</surname><given-names>Cheng-Feng</given-names></name>, <name><surname>Gibbons</surname><given-names>Aridth</given-names></name>, <name><surname>Krapiunaya</surname><given-names>Inna</given-names></name>, <name><surname>Morales-Betoulle</surname><given-names>Maria</given-names></name>, <name><surname>Roguski</surname><given-names>Katherine</given-names></name>, <name><surname>Rasheed</surname><given-names>Mohammad Ata Ur</given-names></name>, <name><surname>Freeman</surname><given-names>Brandi</given-names></name>, <name><surname>Lester</surname><given-names>Sandra</given-names></name>, <name><surname>Mills</surname><given-names>Lisa</given-names></name>, <name><surname>Carroll</surname><given-names>Darin S.</given-names></name>, <name><surname>Owen</surname><given-names>S. Michele</given-names></name>, <name><surname>Johnson</surname><given-names>Jeffrey A.</given-names></name>, <name><surname>Semenova</surname><given-names>Vera</given-names></name>, <name><surname>Blackmore</surname><given-names>Carina</given-names></name>, <name><surname>Blog</surname><given-names>Debra</given-names></name>, <name><surname>Chai</surname><given-names>Shua J.</given-names></name>, <name><surname>Dunn</surname><given-names>Angela</given-names></name>, <name><surname>Hand</surname><given-names>Julie</given-names></name>, <name><surname>Jain</surname><given-names>Seema</given-names></name>, <name><surname>Lindquist</surname><given-names>Scott</given-names></name>, <name><surname>Lynfield</surname><given-names>Ruth</given-names></name>, <name><surname>Pritchard</surname><given-names>Scott</given-names></name>, <name><surname>Sokol</surname><given-names>Theresa</given-names></name>, <name><surname>Sosa</surname><given-names>Lynn</given-names></name>, <name><surname>Turabelidze</surname><given-names>George</given-names></name>, <name><surname>Watkins</surname><given-names>Sharon M.</given-names></name>, <name><surname>Wiesman</surname><given-names>John</given-names></name>, <name><surname>Williams</surname><given-names>Randall W.</given-names></name>, <name><surname>Yendell</surname><given-names>Stephanie</given-names></name>, <name><surname>Schiffer</surname><given-names>Jarad</given-names></name>, and <name><surname>Thornburg</surname><given-names>Natalie J.</given-names></name>. <article-title>Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020</article-title>. <source>JAMA Internal Medicine</source>, <volume>180</volume>(<issue>12</issue>):<fpage>1576</fpage>–<lpage>1586</lpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R54">
                <label>[54]</label>
                <mixed-citation publication-type="journal"><name><surname>Mahajan</surname><given-names>Shiwani</given-names></name>, <name><surname>Srinivasan</surname><given-names>Rajesh</given-names></name>, <name><surname>Redlich</surname><given-names>Carrie A</given-names></name>, <name><surname>Huston</surname><given-names>Sara K</given-names></name>, <name><surname>Anastasio</surname><given-names>Kelly M</given-names></name>, <name><surname>Cashman</surname><given-names>Lisa</given-names></name>, <name><surname>Massey</surname><given-names>Dorothy S</given-names></name>, <name><surname>Dugan</surname><given-names>Andrew</given-names></name>, <name><surname>Witters</surname><given-names>Dan</given-names></name>, <name><surname>Marlar</surname><given-names>Jenny</given-names></name>, <name><surname>Li</surname><given-names>Shu-Xia</given-names></name>, <name><surname>Lin</surname><given-names>Zhenqiu</given-names></name>, <name><surname>Hodge</surname><given-names>Domonique</given-names></name>, <name><surname>Chattopadhyay</surname><given-names>Manas</given-names></name>, <name><surname>Adams</surname><given-names>Mark D</given-names></name>, <name><surname>Lee</surname><given-names>Charles</given-names></name>, <name><surname>Rao</surname><given-names>Lokinendi V</given-names></name>, <name><surname>Stewart</surname><given-names>Chris</given-names></name>, <name><surname>Kuppusamy</surname><given-names>Karthik</given-names></name>, <name><surname>Ko</surname><given-names>Albert I</given-names></name>, and <name><surname>Krumholz</surname><given-names>Harlan M</given-names></name>. <article-title>Seroprevalence of SARS-CoV-2-specific IgG antibodies among adults living in Connecticut: Post-infection prevalence (PIP) study</article-title>. <source>The American Journal of Medicine</source>, <comment>In press</comment>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/j.amjmed.2020.09.024</pub-id></mixed-citation>
              </ref>
              <ref id="R55">
                <label>[55]</label>
                <mixed-citation publication-type="web"><name><surname>Boni</surname><given-names>Maciej F</given-names></name>. <source>SARS-CoV-2 attack rates for Connecticut</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://twitter.com/maciekboni/status/1371847662077632513">https://twitter.com/maciekboni/status/1371847662077632513</ext-link>.</comment><comment>Accessed</comment>: <date-in-citation>2021-03-16</date-in-citation>.</mixed-citation>
              </ref>
              <ref id="R56">
                <label>[56]</label>
                <mixed-citation publication-type="journal"><name><surname>Mahajan</surname><given-names>Shiwani</given-names></name>, <name><surname>Caraballo</surname><given-names>César</given-names></name>, <name><surname>Li</surname><given-names>Shu-Xia</given-names></name>, <name><surname>Dong</surname><given-names>Yike</given-names></name>, <name><surname>Chen</surname><given-names>Lian</given-names></name>, <name><surname>Huston</surname><given-names>Sara K</given-names></name>, <name><surname>Srinivasan</surname><given-names>Rajesh</given-names></name>, <name><surname>Redlich</surname><given-names>Carrie A</given-names></name>, <name><surname>Ko</surname><given-names>Albert I</given-names></name>, <name><surname>Faust</surname><given-names>Jeremy S</given-names></name>, <name><surname>Forman</surname><given-names>Howard P</given-names></name>, and <name><surname>Krumholz</surname><given-names>Harlan M</given-names></name>. <article-title>SARS-CoV-2 infection hospitalization rate and infection fatality rate among the non-congregate population in Connecticut</article-title>. <source>The American Journal of Medicine</source>, <comment>In press</comment>, <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1016/j.amjmed.2021.01.020</pub-id></mixed-citation>
              </ref>
              <ref id="R57">
                <label>[57]</label>
                <mixed-citation publication-type="journal"><name><surname>Waltenburg</surname><given-names>Michelle A</given-names></name>, <name><surname>Victoroff</surname><given-names>Tristan</given-names></name>, <name><surname>Rose</surname><given-names>Charles E</given-names></name>, <name><surname>Butterfield</surname><given-names>Marilee</given-names></name>, <name><surname>Jervis</surname><given-names>Rachel H</given-names></name>, <name><surname>Fedak</surname><given-names>Kristen M</given-names></name>, <name><surname>Gabel</surname><given-names>Julie A</given-names></name>, <name><surname>Feldpausch</surname><given-names>Amanda</given-names></name>, <name><surname>Dunne</surname><given-names>Eileen M</given-names></name>, <name><surname>Austin</surname><given-names>Connie</given-names></name>, <name><surname>Ahmed</surname><given-names>Farah S.</given-names></name>, <name><surname>Tubach</surname><given-names>Sheri</given-names></name>, <name><surname>Rhea</surname><given-names>Charles</given-names></name>, <name><surname>Krueger</surname><given-names>Anna</given-names></name>, <name><surname>Crum</surname><given-names>David A.</given-names></name>, <name><surname>Vostok</surname><given-names>Johanna</given-names></name>, <name><surname>Moore</surname><given-names>Michael J.</given-names></name>, <name><surname>Turabelidze</surname><given-names>George</given-names></name>, <name><surname>Stover</surname><given-names>Derry</given-names></name>, <name><surname>Donahue</surname><given-names>Matthew</given-names></name>, <name><surname>Edge</surname><given-names>Karen</given-names></name>, <name><surname>Gutierrez</surname><given-names>Bernadette</given-names></name>, <name><surname>Kline</surname><given-names>Kelly E.</given-names></name>, <name><surname>Martz</surname><given-names>Nichole</given-names></name>, <name><surname>Rajotte</surname><given-names>James C.</given-names></name>, <name><surname>Julian</surname><given-names>Ernest</given-names></name>, <name><surname>Diedhiou</surname><given-names>Abdoulaye</given-names></name>, <name><surname>Radcliffe</surname><given-names>Rachel</given-names></name>, <name><surname>Clayton</surname><given-names>Joshua L.</given-names></name>, <name><surname>Ortbahn</surname><given-names>Dustin</given-names></name>, <name><surname>Cummins</surname><given-names>Jason</given-names></name>, <name><surname>Barbeau</surname><given-names>Bree</given-names></name>, <name><surname>Murphy</surname><given-names>Julia</given-names></name>, <name><surname>Darby</surname><given-names>Brandy</given-names></name>, <name><surname>Graff</surname><given-names>Nicholas R.</given-names></name>, <name><surname>Dostal</surname><given-names>Tia K. H.</given-names></name>, <name><surname>Pray</surname><given-names>Ian W.</given-names></name>, <name><surname>Tillman</surname><given-names>Courtney</given-names></name>, <name><surname>Dittrich</surname><given-names>Michelle M.</given-names></name>, <name><surname>Burns-Grant</surname><given-names>Gail</given-names></name>, <name><surname>Lee</surname><given-names>Sooji</given-names></name>, <name><surname>Spieckerman</surname><given-names>Alisa</given-names></name>, <name><surname>Iqbal</surname><given-names>Kashif</given-names></name>, <name><surname>Griffing</surname><given-names>Sean M.</given-names></name>, <name><surname>Lawson</surname><given-names>Alicia</given-names></name>, <name><surname>Mainzer</surname><given-names>Hugh M.</given-names></name>, <name><surname>Bealle</surname><given-names>Andreea E.</given-names></name>, <name><surname>Edding</surname><given-names>Erika</given-names></name>, <name><surname>Arnold</surname><given-names>Kathryn E.</given-names></name>, <name><surname>Rodriguez</surname><given-names>Tomas</given-names></name>, <name><surname>Merkle</surname><given-names>Sarah</given-names></name>, <name><surname>Pettrone</surname><given-names>Kristen</given-names></name>, <name><surname>Schlanger</surname><given-names>Karen</given-names></name>, <name><surname>LaBar</surname><given-names>Kristin</given-names></name>, <name><surname>Hendricks</surname><given-names>Kate</given-names></name>, <name><surname>Lasry</surname><given-names>Arielle</given-names></name>, <name><surname>Krishnasamy</surname><given-names>Vikram</given-names></name>, <name><surname>Walke</surname><given-names>Henry T.</given-names></name>, <name><surname>Rose</surname><given-names>Dale A.</given-names></name>, <name><surname>Honein</surname><given-names>Margaret A.</given-names></name>, and <collab>COVID-19 Response Team</collab>. <article-title>Update: COVID-19 among workers in meat and poultry processing facilities —- United States, April–May 2020</article-title>. <source>Morbidity and Mortality Weekly Report</source>, <volume>69</volume>(<issue>27</issue>):<fpage>887</fpage>–<lpage>892</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32644986</pub-id></mixed-citation>
              </ref>
              <ref id="R58">
                <label>[58]</label>
                <mixed-citation publication-type="journal"><name><surname>Pitzer</surname><given-names>Virginia E</given-names></name>, <name><surname>Chitwood</surname><given-names>Melanie</given-names></name>,<name><surname>Havumaki</surname><given-names>Joshua</given-names></name>, <name><surname>Menzies</surname><given-names>Nicolas A</given-names></name>, <name><surname>Perniciaro</surname><given-names>Stephanie</given-names></name>, <name><surname>Warren</surname><given-names>Joshua L</given-names></name>, <name><surname>Weinberger</surname><given-names>Daniel M</given-names></name>, and <name><surname>Cohen</surname><given-names>Ted</given-names></name>. <article-title>The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States</article-title>. <source>MedRxiv</source>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1101/2020.04.20.20073338</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.04.20.20073338v1">https://www.medrxiv.org/content/10.1101/2020.04.20.20073338v1</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R59">
                <label>[59]</label>
                <mixed-citation publication-type="journal"><name><surname>Murray</surname><given-names>Iain</given-names></name>, <name><surname>Adams</surname><given-names>Ryan</given-names></name>, and <name><surname>MacKay</surname><given-names>David</given-names></name>. <article-title>Elliptical slice sampling</article-title>. In <source>Proceedings of the thirteenth international conference on artificial intelligence and statistics</source>, pages <fpage>541</fpage>–<lpage>548</lpage>, <year>2010</year>.</mixed-citation>
              </ref>
              <ref id="R60">
                <label>[60]</label>
                <mixed-citation publication-type="journal"><name><surname>Oran</surname><given-names>Daniel P</given-names></name> and <name><surname>Topol</surname><given-names>Eric J</given-names></name>. <article-title>Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review</article-title>. <source>Annals of Internal Medicine</source>, <volume>173</volume>(<issue>5</issue>):<fpage>362</fpage>–<lpage>367</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32491919</pub-id></mixed-citation>
              </ref>
              <ref id="R61">
                <label>[61]</label>
                <mixed-citation publication-type="journal"><name><surname>Buitrago-Garcia</surname><given-names>Diana</given-names></name>, <name><surname>Egli-Gany</surname><given-names>Dianne</given-names></name>, <name><surname>Counotte</surname><given-names>Michel J</given-names></name>, <name><surname>Hossmann</surname><given-names>Stefanie</given-names></name>, <name><surname>Imeri</surname><given-names>Hira</given-names></name>, <name><surname>Ipekci</surname><given-names>Aziz Mert</given-names></name>, <name><surname>Salanti</surname><given-names>Georgia</given-names></name>, and <name><surname>Low</surname><given-names>Nicola</given-names></name>. <article-title>Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis</article-title>. <source>PLoS medicine</source>, <volume>17</volume>(<issue>9</issue>):<fpage>e1003346</fpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32960881</pub-id></mixed-citation>
              </ref>
              <ref id="R62">
                <label>[62]</label>
                <mixed-citation publication-type="web"><collab>Centers for Disease Control and Prevention</collab>. <source>COVID-19 Pandemic Planning Scenarios</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html</ext-link></comment>, <year>2021</year>. <comment>Accessed</comment>: <date-in-citation>2021-01-18</date-in-citation>.</mixed-citation>
              </ref>
              <ref id="R63">
                <label>[63]</label>
                <mixed-citation publication-type="journal"><name><surname>Nishiura</surname><given-names>Hiroshi</given-names></name>, <name><surname>Kobayashi</surname><given-names>Tetsuro</given-names></name>, <name><surname>Miyama</surname><given-names>Takeshi</given-names></name>, <name><surname>Suzuki</surname><given-names>Ayako</given-names></name>, <name><surname>Jung</surname><given-names>Sung-Mok</given-names></name>, <name><surname>Hayashi</surname><given-names>Katsuma</given-names></name>, <name><surname>Kinoshita</surname><given-names>Ryo</given-names></name>, <name><surname>Yang</surname><given-names>Yichi</given-names></name>, <name><surname>Yuan</surname><given-names>Baoyin</given-names></name>, <article-title>Andrei R Akhmetzhanov, and Natalie M Linton. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)</article-title>. <source>International Journal of Infectious Diseases</source>, <volume>94</volume>:<fpage>154</fpage>–<lpage>155</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32179137</pub-id></mixed-citation>
              </ref>
              <ref id="R64">
                <label>[64]</label>
                <mixed-citation publication-type="journal"><name><surname>Mizumoto</surname><given-names>Kenji</given-names></name>, <name><surname>Kagaya</surname><given-names>Katsushi</given-names></name>, <name><surname>Zarebski</surname><given-names>Alexander</given-names></name>, and <name><surname>Chowell</surname><given-names>Gerardo</given-names></name>. <article-title>Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020</article-title>. <source>Eurosurveillance</source>, <volume>25</volume>(<issue>10</issue>):<fpage>2000180</fpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R65">
                <label>[65]</label>
                <mixed-citation publication-type="journal"><name><surname>Timothy W Russell</surname><given-names>Joel Hellewell</given-names></name>, <name><surname>Christopher I Jarvis</surname><given-names>Kevin Van Zandvoort</given-names></name>, <name><surname>Abbott</surname><given-names>Sam</given-names></name>, <name><surname>Ratnayake</surname><given-names>Ruwan</given-names></name>, <name><surname>Flasche</surname><given-names>Stefan</given-names></name>, <name><surname>Eggo</surname><given-names>Rosalind M</given-names></name>, <name><surname>Edmunds</surname><given-names>W John</given-names></name>, and <name><surname>Kucharski</surname><given-names>Adam J</given-names></name>. <article-title>Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020</article-title>. <source>Eurosurveillance</source>, <volume>25</volume>(<issue>12</issue>):<fpage>2000256</fpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R66">
                <label>[66]</label>
                <mixed-citation publication-type="journal"><name><surname>Byrne</surname><given-names>Andrew William</given-names></name>, <name><surname>McEvoy</surname><given-names>David</given-names></name>, <name><surname>Collins</surname><given-names>Aine B</given-names></name>, <name><surname>Hunt</surname><given-names>Kevin</given-names></name>, <name><surname>Casey</surname><given-names>Miriam</given-names></name>, <name><surname>Barber</surname><given-names>Ann</given-names></name>, <name><surname>Butler</surname><given-names>Francis</given-names></name>, <name><surname>Griffin</surname><given-names>John</given-names></name>, <name><surname>Lane</surname><given-names>Elizabeth A</given-names></name>, <name><surname>McAloon</surname><given-names>Conor</given-names></name>, <name><surname>O’Brien</surname><given-names>Kirsty</given-names></name>, <name><surname>Wall</surname><given-names>Patrick</given-names></name>, <name><surname>Walsh</surname><given-names>Kieran A</given-names></name>, and <name><surname>More</surname><given-names>Simon J</given-names></name>. <article-title>Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases</article-title>. <source>BMJ Open</source>, <volume>10</volume>(<issue>8</issue>), <year>2020</year>. <comment>ISSN 2044–6055.</comment> doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2020-039856</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://bmjopen.bmj.com/content/10/8/e039856">https://bmjopen.bmj.com/content/10/8/e039856</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R67">
                <label>[67]</label>
                <mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>Wycliffe E</given-names></name>, <name><surname>Li</surname><given-names>Zongbin</given-names></name>, <name><surname>Chiew</surname><given-names>Calvin J</given-names></name>, <name><surname>Yong</surname><given-names>Sarah E</given-names></name>, <name><surname>Toh</surname><given-names>Matthias P</given-names></name>, and <name><surname>Lee</surname><given-names>Vernon J</given-names></name>. <article-title>Presymptomatic transmission of SARS-CoV-2 – Singapore, January 23–March 16, 2020</article-title>. <source>Morbidity and Mortality Weekly Report</source>, <volume>69</volume>(<issue>14</issue>):<fpage>411</fpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32271722</pub-id></mixed-citation>
              </ref>
              <ref id="R68">
                <label>[68]</label>
                <mixed-citation publication-type="journal"><name><surname>Biggerstaff</surname><given-names>Matthew</given-names></name>, <name><surname>Cowling</surname><given-names>Benjamin J</given-names></name>, <name><surname>Cucunubá</surname><given-names>Zulma M</given-names></name>, <name><surname>Dinh</surname><given-names>Linh</given-names></name>, <name><surname>Ferguson</surname><given-names>Neil M</given-names></name>, <name><surname>Gao</surname><given-names>Huizhi</given-names></name>, <name><surname>Hill</surname><given-names>Verity</given-names></name>, <name><surname>Imai</surname><given-names>Natsuko</given-names></name>, <name><surname>Johansson</surname><given-names>Michael A</given-names></name>, <name><surname>Kada</surname><given-names>Sarah</given-names></name>, <name><surname>Morgan</surname><given-names>Oliver</given-names></name>, <name><surname>Piontti</surname><given-names>Ana Pastore y</given-names></name>, <name><surname>Polonsky</surname><given-names>Jonathan A.</given-names></name>, <name><surname>Prasad</surname><given-names>Pragati Venkata</given-names></name>, <name><surname>Quandelacy</surname><given-names>Talia M.</given-names></name>, <name><surname>Rambaut</surname><given-names>Andrew</given-names></name>, <name><surname>Tappero</surname><given-names>Jordan W.</given-names></name>, <name><surname>Vandemaele</surname><given-names>Katelijn A.</given-names></name>, <name><surname>Vespignani</surname><given-names>Alessandro</given-names></name>, <name><surname>Warmbrod</surname><given-names>K. Lane</given-names></name>, <name><surname>Wong</surname><given-names>Jessica Y.</given-names></name>, and the <collab>WHO COVID-19 Modelling Parameters Group</collab>. <article-title>Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19</article-title>. <source>Emerging Infectious Diseases</source>, <volume>26</volume>(<issue>11</issue>), <year>2020</year>. doi: <pub-id pub-id-type="doi">10.3201/eid2611.201074</pub-id></mixed-citation>
              </ref>
              <ref id="R69">
                <label>[69]</label>
                <mixed-citation publication-type="journal"><name><surname>McAloon</surname><given-names>Conor</given-names></name>, <name><surname>Collins</surname><given-names>Áine</given-names></name>, <name><surname>Hunt</surname><given-names>Kevin</given-names></name>, <name><surname>Barber</surname><given-names>Ann</given-names></name>, <name><surname>Byrne</surname><given-names>Andrew W</given-names></name>, <name><surname>Butler</surname><given-names>Francis</given-names></name>, <name><surname>Casey</surname><given-names>Miriam</given-names></name>, <name><surname>Griffin</surname><given-names>John</given-names></name>, <name><surname>Lane</surname><given-names>Elizabeth</given-names></name>, <name><surname>McEvoy</surname><given-names>David</given-names></name>, <name><surname>Wall</surname><given-names>Patrick</given-names></name>, <name><surname>Green</surname><given-names>Martin</given-names></name>, <name><surname>O’Grady</surname><given-names>Luke</given-names></name>, and <name><surname>More</surname><given-names>Simon J</given-names></name>. <article-title>Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research</article-title>. <source>BMJ Open</source>, <volume>10</volume>(<issue>8</issue>):<fpage>e039652</fpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2020-039652</pub-id></mixed-citation>
              </ref>
              <ref id="R70">
                <label>[70]</label>
                <mixed-citation publication-type="journal"><name><surname>Lauer</surname><given-names>Stephen A</given-names></name>, <name><surname>Grantz</surname><given-names>Kyra H</given-names></name>, <name><surname>Bi</surname><given-names>Qifang</given-names></name>, <name><surname>Jones</surname><given-names>Forrest K</given-names></name>, <name><surname>Zheng</surname><given-names>Qulu</given-names></name>, <name><surname>Meredith</surname><given-names>Hannah R</given-names></name>, <name><surname>Azman</surname><given-names>Andrew S</given-names></name>, <name><surname>Reich</surname><given-names>Nicholas G</given-names></name>, and <name><surname>Lessler</surname><given-names>Justin</given-names></name>. <article-title>The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application</article-title>. <source>Annals of Internal Medicine</source>, <volume>172</volume>(<issue>9</issue>): <fpage>577</fpage>–<lpage>582</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32150748</pub-id></mixed-citation>
              </ref>
              <ref id="R71">
                <label>[71]</label>
                <mixed-citation publication-type="journal"><name><surname>Backer</surname><given-names>Jantien A</given-names></name>, <name><surname>Klinkenberg</surname><given-names>Don</given-names></name>, and <name><surname>Wallinga</surname><given-names>Jacco</given-names></name>. <article-title>Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020</article-title>. <source>Eurosurveillance</source>, <volume>25</volume>(<issue>5</issue>):<fpage>2000062</fpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R72">
                <label>[72]</label>
                <mixed-citation publication-type="journal"><name><surname>Linton</surname><given-names>Natalie M</given-names></name>, <name><surname>Kobayashi</surname><given-names>Tetsuro</given-names></name>, <name><surname>Yang</surname><given-names>Yichi</given-names></name>, <name><surname>Hayashi</surname><given-names>Katsuma</given-names></name>, <name><surname>Akhmetzhanov</surname><given-names>Andrei R</given-names></name>, <name><surname>Jung</surname><given-names>Sung-mok</given-names></name>, <name><surname>Yuan</surname><given-names>Baoyin</given-names></name>, <name><surname>Kinoshita</surname><given-names>Ryo</given-names></name>, and <name><surname>Nishiura</surname><given-names>Hiroshi</given-names></name>. <article-title>Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data</article-title>. <source>Journal of Clinical Medicine</source>, <volume>9</volume>(<issue>2</issue>):<fpage>538</fpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R73">
                <label>[73]</label>
                <mixed-citation publication-type="journal"><name><surname>Qin</surname><given-names>Jing</given-names></name>, <name><surname>You</surname><given-names>Chong</given-names></name>, <name><surname>Lin</surname><given-names>Qiushi</given-names></name>, <name><surname>Hu</surname><given-names>Taojun</given-names></name>, <name><surname>Yu</surname><given-names>Shicheng</given-names></name>, and <name><surname>Zhou</surname><given-names>Xiao-Hua</given-names></name>. <article-title>Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study</article-title>. <source>Science Advances</source>, <volume>6</volume>(<issue>33</issue>), <fpage>2020</fpage>. doi: <pub-id pub-id-type="doi">10.1126/sciadv.abc1202</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://advances.sciencemag.org/content/6/33/eabc1202">https://advances.sciencemag.org/content/6/33/eabc1202</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R74">
                <label>[74]</label>
                <mixed-citation publication-type="journal"><name><surname>Cevik</surname><given-names>Muge</given-names></name>, <name><surname>Tate</surname><given-names>Matthew</given-names></name>, <name><surname>Lloyd</surname><given-names>Ollie</given-names></name>, <name><surname>Maraolo</surname><given-names>Alberto Enrico</given-names></name>, <name><surname>Schafers</surname><given-names>Jenna</given-names></name>, and <name><surname>Ho</surname><given-names>Antonia</given-names></name>. <article-title>SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis</article-title>. <source>The Lancet Microbe</source>, <volume>2</volume>(<issue>1</issue>):<fpage>e13</fpage>–<lpage>e22</lpage>, <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1016/S2666-5247(20)30172-5</pub-id><pub-id pub-id-type="pmid">33521734</pub-id></mixed-citation>
              </ref>
              <ref id="R75">
                <label>[75]</label>
                <mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>Kieran A</given-names></name>, <name><surname>Jordan</surname><given-names>Karen</given-names></name>, <name><surname>Clyne</surname><given-names>Barbara</given-names></name>, <name><surname>Rohde</surname><given-names>Daniela</given-names></name>, <name><surname>Drummond</surname><given-names>Linda</given-names></name>, <name><surname>Byrne</surname><given-names>Paula</given-names></name>, <name><surname>Ahern</surname><given-names>Susan</given-names></name>, <name><surname>Carty</surname><given-names>Paul G</given-names></name>, <name><surname>O’Brien</surname><given-names>Kirsty K</given-names></name>, <name><surname>O’Murchu</surname><given-names>Eamon</given-names></name>, <name><surname>O’Neill</surname><given-names>Michelle</given-names></name>, <name><surname>Smith</surname><given-names>Susan M</given-names></name>, <name><surname>Ryan</surname><given-names>Mairin</given-names></name>, and <name><surname>Harrington</surname><given-names>Patricia</given-names></name>. <article-title>SARS-CoV-2 detection, viral load and infectivity over the course of an infection</article-title>. <source>Journal of Infection</source>, <volume>81</volume>(<issue>3</issue>):<fpage>357</fpage>–<lpage>371</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2020.06.067</pub-id></mixed-citation>
              </ref>
              <ref id="R76">
                <label>[76]</label>
                <mixed-citation publication-type="journal"><name><surname>Qiu</surname><given-names>Xueting</given-names></name>, <name><surname>Nergiz</surname><given-names>Ali Ihsan</given-names></name>, <name><surname>Maraolo</surname><given-names>Alberto Enrico</given-names></name>, <name><surname>Bogoch</surname><given-names>Isaac I.</given-names></name>, <name><surname>Low</surname><given-names>Nicola</given-names></name>, and <name><surname>Cevik</surname><given-names>Muge</given-names></name>. <article-title>The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission — a living systematic review</article-title>. <source>Clinical Microbiology and Infection</source>, <volume>27</volume>(<issue>4</issue>):<fpage>511</fpage>–<lpage>519</lpage>, <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1016/j.cmi.2021.01.011</pub-id><pub-id pub-id-type="pmid">33484843</pub-id></mixed-citation>
              </ref>
              <ref id="R77">
                <label>[77]</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Rongrong</given-names></name>, <name><surname>Gui</surname><given-names>Xien</given-names></name>, and <name><surname>Xiong</surname><given-names>Yong</given-names></name>. <article-title>Comparison of clinical characteristics of patients with asymptomatic vs symptomatic coronavirus disease 2019 in Wuhan, China</article-title>. <source>JAMA Network Open</source>, <volume>3</volume>(<issue>5</issue>):<fpage>e2010182</fpage>–<lpage>e2010182</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32459353</pub-id></mixed-citation>
              </ref>
              <ref id="R78">
                <label>[78]</label>
                <mixed-citation publication-type="journal"><name><surname>Kieran A Walsh</surname><given-names>Susan Spillane</given-names></name>, <name><surname>Comber</surname><given-names>Laura</given-names></name>, <name><surname>Cardwell</surname><given-names>Karen</given-names></name>, <name><surname>Harrington</surname><given-names>Patricia</given-names></name>, <name><surname>Connell</surname><given-names>Jeff</given-names></name>, <name><surname>Teljeur</surname><given-names>Conor</given-names></name>, <name><surname>Broderick</surname><given-names>Natasha</given-names></name>, <name><surname>de Gascun</surname><given-names>Cillian F</given-names></name>, <name><surname>Smith</surname><given-names>Susan M</given-names></name>, <name><surname>Ryan</surname><given-names>Mairin</given-names></name>, and <name><surname>O’Neill</surname><given-names>Michelle</given-names></name>. <article-title>The duration of infectiousness of individuals infected with SARS-CoV-2</article-title>. <source>Journal of Infection</source>, <volume>81</volume>(<issue>6</issue>):<fpage>847</fpage>–<lpage>856</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2020.10.009</pub-id></mixed-citation>
              </ref>
              <ref id="R79">
                <label>[79]</label>
                <mixed-citation publication-type="journal"><name><surname>Roman Wölfel</surname><given-names>Victor M. Corman</given-names></name>, <name><surname>Guggemos</surname><given-names>Wolfgang</given-names></name>, <name><surname>Seilmaier</surname><given-names>Michael</given-names></name>, <name><surname>Zange</surname><given-names>Sabine</given-names></name>, <name><surname>Müller</surname><given-names>Marcel A.</given-names></name>, <name><surname>Niemeyer</surname><given-names>Daniela</given-names></name>, <name><surname>Jones</surname><given-names>Terry C.</given-names></name>, <name><surname>Vollmar</surname><given-names>Patrick</given-names></name>, <name><surname>Rothe</surname><given-names>Camilla</given-names></name>, <name><surname>Hoelscher</surname><given-names>Michael</given-names></name>, <name><surname>Bleicker</surname><given-names>Tobias</given-names></name>, <name><surname>Brünink</surname><given-names>Sebastian</given-names></name>, <name><surname>Schneider</surname><given-names>Julia</given-names></name>, <name><surname>Ehmann</surname><given-names>Rosina</given-names></name>, <name><surname>Zwirglmaier</surname><given-names>Katrin</given-names></name>, <name><surname>Drosten</surname><given-names>Christian</given-names></name>, and <name><surname>Wendtner</surname><given-names>Clemens</given-names></name>. <article-title>Virological assessment of hospitalized patients with COVID-2019</article-title>. <source>Nature</source>, <volume>581</volume>(<issue>7809</issue>):<fpage>465</fpage>–<lpage>469</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32235945</pub-id></mixed-citation>
              </ref>
              <ref id="R80">
                <label>[80]</label>
                <mixed-citation publication-type="journal"><name><surname>Evoy</surname><given-names>David Mc</given-names></name>, <name><surname>McAloon</surname><given-names>Conor G</given-names></name>, <name><surname>Collins</surname><given-names>Aine B</given-names></name>, <name><surname>Hunt</surname><given-names>Kevin</given-names></name>, <name><surname>Butler</surname><given-names>Francis</given-names></name>, <name><surname>Byrne</surname><given-names>Andrew W</given-names></name>, <name><surname>Casey</surname><given-names>Miriam</given-names></name>, <name><surname>Barber</surname><given-names>Ann</given-names></name>, <name><surname>Griffin</surname><given-names>John M</given-names></name>, <name><surname>Lane</surname><given-names>Elizabeth A</given-names></name>, <name><surname>Wall</surname><given-names>Patrick</given-names></name>, and <name><surname>More</surname><given-names>Simon J</given-names></name>. <article-title>The relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review</article-title>. <source>medRxiv</source>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1101/2020.07.30.20165084</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.07.30.20165084v1">https://www.medrxiv.org/content/10.1101/2020.07.30.20165084v1</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R81">
                <label>[81]</label>
                <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Daihai</given-names></name>, <name><surname>Zhao</surname><given-names>Shi</given-names></name>, <name><surname>Lin</surname><given-names>Qianying</given-names></name>, <name><surname>Zhuang</surname><given-names>Zian</given-names></name>, <name><surname>Cao</surname><given-names>Peihua</given-names></name>, <name><surname>Wang</surname><given-names>Maggie H</given-names></name>, and <name><surname>Yang</surname><given-names>Lin</given-names></name>. <article-title>The relative transmissibility of asymptomatic COVID-19 infections among close contacts</article-title>. <source>International Journal of Infectious Diseases</source>, <volume>94</volume>:<fpage>145</fpage>–<lpage>147</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32315808</pub-id></mixed-citation>
              </ref>
              <ref id="R82">
                <label>[82]</label>
                <mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <article-title>Discontinuation of isolation for persons with COVID-19 not in healthcare settings</article-title>. <source>interim guidance</source>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html</ext-link></comment>, <year>2020</year>. <comment>Accessed</comment>: <date-in-citation>2021-01-18</date-in-citation>.</mixed-citation>
              </ref>
              <ref id="R83">
                <label>[83]</label>
                <mixed-citation publication-type="journal"><name><surname>Garg</surname><given-names>Shikha</given-names></name>, <name><surname>Kim</surname><given-names>Lindsay</given-names></name>, <name><surname>Whitaker</surname><given-names>Michael</given-names></name>, <name><surname>O’Halloran</surname><given-names>Alissa</given-names></name>, <name><surname>Cummings</surname><given-names>Charisse</given-names></name>, <name><surname>Holstein</surname><given-names>Rachel</given-names></name>, <name><surname>Prill</surname><given-names>Mila</given-names></name>, <name><surname>Chai</surname><given-names>Shua J</given-names></name>, <name><surname>Kirley</surname><given-names>Pam D</given-names></name>, <name><surname>Alden</surname><given-names>Nisha B</given-names></name>, <name><surname>Kawasaki</surname><given-names>Breanna</given-names></name>, <name><surname>Yousey-Hindes</surname><given-names>Kimberly</given-names></name>, <name><surname>Niccolai</surname><given-names>Linda</given-names></name>, <name><surname>Anderson</surname><given-names>Evan J</given-names></name>, <name><surname>Openo</surname><given-names>Kyle P</given-names></name>, <name><surname>Weigel</surname><given-names>Andrew</given-names></name>, <name><surname>Monroe</surname><given-names>Maya L</given-names></name>, <name><surname>Ryan</surname><given-names>Patricia</given-names></name>, <name><surname>Henderson</surname><given-names>Justin</given-names></name>, <name><surname>Kim</surname><given-names>Sue</given-names></name>, <name><surname>Como-Sabetti</surname><given-names>Kathy</given-names></name>, <name><surname>Lynfield</surname><given-names>Ruth</given-names></name>, <name><surname>Sosin</surname><given-names>Daniel</given-names></name>, <name><surname>Torres</surname><given-names>Salina</given-names></name>, <name><surname>Muse</surname><given-names>Alison</given-names></name>, <name><surname>Bennett</surname><given-names>Nancy M</given-names></name>, <name><surname>Billing</surname><given-names>Laurie</given-names></name>, <name><surname>Sutton</surname><given-names>Melissa</given-names></name>, <name><surname>West</surname><given-names>Nicole</given-names></name>, <name><surname>Schaffner</surname><given-names>William</given-names></name>, <name><surname>Talbot</surname><given-names>H. Keipp</given-names></name>, <name><surname>Clarissa</surname><given-names>Aquino</given-names></name>, <name><surname>George</surname><given-names>Andrea</given-names></name>, <name><surname>Budd</surname><given-names>Alicia</given-names></name>, <name><surname>Brammer</surname><given-names>Lynnette</given-names></name>, <name><surname>Langley</surname><given-names>Gayle</given-names></name>, <name><surname>Hall</surname><given-names>Aron J</given-names></name>, and <name><surname>Fry</surname><given-names>Alicia</given-names></name>. <article-title>Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 states, March 1–30, 2020</article-title>. <source>MMWR. Morbidity and Mortality Weekly Report</source>, <volume>69</volume>(<issue>15</issue>):<fpage>458</fpage>–<lpage>464</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm6915e3</pub-id><pub-id pub-id-type="pmid">32298251</pub-id></mixed-citation>
              </ref>
              <ref id="R84">
                <label>[84]</label>
                <mixed-citation publication-type="journal"><name><surname>Perez-Guzman</surname><given-names>Pablo N</given-names></name>, <name><surname>Daunt</surname><given-names>Anna</given-names></name>, <name><surname>Mukherjee</surname><given-names>Sujit</given-names></name>, <name><surname>Crook</surname><given-names>Peter</given-names></name>, <name><surname>Forlano</surname><given-names>Roberta</given-names></name>, <name><surname>Kont</surname><given-names>Mara D</given-names></name>, <name><surname>Løchen</surname><given-names>Alessandra</given-names></name>, <name><surname>Vollmer</surname><given-names>Michaela</given-names></name>, <name><surname>Middleton</surname><given-names>Paul</given-names></name>, <name><surname>Judge</surname><given-names>Rebekah</given-names></name>, <name><surname>Harlow</surname><given-names>Chris</given-names></name>, <name><surname>Soubieres</surname><given-names>Anet</given-names></name>, <name><surname>Cooke</surname><given-names>Graham</given-names></name>, <name><surname>White</surname><given-names>Peter J</given-names></name>, <name><surname>Hallett</surname><given-names>Timothy B</given-names></name>, <name><surname>Aylin</surname><given-names>Paul</given-names></name>, <name><surname>Ferguson</surname><given-names>Neil</given-names></name>, <name><surname>Hauck</surname><given-names>Katharina</given-names></name>, <name><surname>Thursz</surname><given-names>Mark</given-names></name>, and <name><surname>Nayagam</surname><given-names>Shevanthi</given-names></name>. <article-title>Clinical characteristics and predictors of outcomes of hospitalized patients with coronavirus disease 2019 in a multiethnic London national health service trust: a retrospective cohort study</article-title>. <source>Clinical Infectious Diseases</source>, <fpage>ciaa1091</fpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciaa1091</pub-id><pub-id pub-id-type="pmid">32766823</pub-id></mixed-citation>
              </ref>
              <ref id="R85">
                <label>[85]</label>
                <mixed-citation publication-type="journal"><name><surname>Furukawa</surname><given-names>Nathan W</given-names></name>, <name><surname>Brooks</surname><given-names>John T</given-names></name>, and <name><surname>Sobel</surname><given-names>Jeremy</given-names></name>. <article-title>Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic</article-title>. <source>Emerging Infectious Diseases</source>, <volume>26</volume> (<issue>7</issue>), <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R86">
                <label>[86]</label>
                <mixed-citation publication-type="journal"><name><surname>Emery</surname><given-names>Jon C</given-names></name>, <name><surname>Russel</surname><given-names>Timothy W</given-names></name>, <name><surname>Liu</surname><given-names>Yang</given-names></name>, <name><surname>Hellewell</surname><given-names>Joel</given-names></name>, <name><surname>Pearson</surname><given-names>Carl AB</given-names></name>, <collab>CMMID COVID-19 Working Group</collab>, <name><surname>Knight</surname><given-names>Gwen M</given-names></name>, <name><surname>Eggo</surname><given-names>Rosalind M</given-names></name>, <name><surname>Kucharski</surname><given-names>Adam J</given-names></name>, <name><surname>Funk</surname><given-names>Sebastian</given-names></name>, <name><surname>Flasche</surname><given-names>Stefan</given-names></name>, and <name><surname>Houben</surname><given-names>Rein MGJ</given-names></name>. <article-title>The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship</article-title>. <source>eLife</source>, <volume>9</volume>(<issue>e58699</issue>), <fpage>2020</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.58699</pub-id></mixed-citation>
              </ref>
              <ref id="R87">
                <label>[87]</label>
                <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Xi</given-names></name>, <name><surname>Lau</surname><given-names>Eric H. Y.</given-names></name>, <name><surname>Wu</surname><given-names>Peng</given-names></name>, <name><surname>Deng</surname><given-names>Xilong</given-names></name>, <name><surname>Wang</surname><given-names>Jian</given-names></name>, <name><surname>Hao</surname><given-names>Xinxin</given-names></name>, <name><surname>Lau</surname><given-names>Yiu Chung</given-names></name>, <name><surname>Wong</surname><given-names>Jessica Y.</given-names></name>, <name><surname>Guan</surname><given-names>Yujuan</given-names></name>, <name><surname>Tan</surname><given-names>Xinghua</given-names></name>, <name><surname>Mo</surname><given-names>Xiaoneng</given-names></name>, <name><surname>Chen</surname><given-names>Yanqing</given-names></name>, <name><surname>Liao</surname><given-names>Baolin</given-names></name>, <name><surname>Chen</surname><given-names>Weilie</given-names></name>, <name><surname>Hu</surname><given-names>Fengyu</given-names></name>, <name><surname>Zhang</surname><given-names>Qing</given-names></name>, <name><surname>Zhong</surname><given-names>Mingqiu</given-names></name>, <name><surname>Wu</surname><given-names>Yanrong</given-names></name>, <name><surname>Zhao</surname><given-names>Lingzhai</given-names></name>, <name><surname>Zhang</surname><given-names>Fuchun</given-names></name>, <name><surname>Cowling</surname><given-names>Benjamin J.</given-names></name>, <name><surname>Li</surname><given-names>Fang</given-names></name>, and <name><surname>Leung</surname><given-names>Gabriel M.</given-names></name>. <article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title>. <source>Nature Medicine</source>, <volume>26</volume>(<issue>5</issue>): <fpage>672</fpage>–<lpage>675</lpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R88">
                <label>[88]</label>
                <mixed-citation publication-type="journal"><name><surname>Yanes-Lane</surname><given-names>Mercedes</given-names></name>, <name><surname>Winters</surname><given-names>Nicholas</given-names></name>, <name><surname>Fregonese</surname><given-names>Federica</given-names></name>, <name><surname>Bastos</surname><given-names>Mayara</given-names></name>, <name><surname>Perlman-Arrow</surname><given-names>Sara</given-names></name>, <name><surname>Campbell</surname><given-names>Jonathon R</given-names></name>, and <name><surname>Menzies</surname><given-names>Dick</given-names></name>. <article-title>Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis</article-title>. <source>PloS one</source>, <volume>15</volume>(<issue>11</issue>):<fpage>e0241536</fpage>, <year>2020</year>.<pub-id pub-id-type="pmid">33141862</pub-id></mixed-citation>
              </ref>
              <ref id="R89">
                <label>[89]</label>
                <mixed-citation publication-type="journal"><name><surname>Pollán</surname><given-names>Marina</given-names></name>, <name><surname>Pérez-Gómez</surname><given-names>Beatriz</given-names></name>, <name><surname>Pastor-Barriuso</surname><given-names>Roberto</given-names></name>, <name><surname>Oteo</surname><given-names>Jesús</given-names></name>, <name><surname>Hernán</surname><given-names>Miguel A</given-names></name>, <name><surname>Pérez-Olmeda</surname><given-names>Mayte</given-names></name>, <name><surname>Sanmartín</surname><given-names>Jose L</given-names></name>, <name><surname>Fernández-García</surname><given-names>Aurora</given-names></name>, <name><surname>Cruz</surname><given-names>Israel</given-names></name>, <article-title>Nerea Fernández de Larrea, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study</article-title>. <source>The Lancet</source>, <volume>396</volume>(<issue>10250</issue>):<fpage>535</fpage>–<lpage>544</lpage>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R90">
                <label>[90]</label>
                <mixed-citation publication-type="journal"><name><surname>Ward</surname><given-names>Helen</given-names></name>, <name><surname>Christina J Atchison</surname><given-names>Matthew Whitaker</given-names></name>, <name><surname>Ainslie</surname><given-names>Kylie E. C.</given-names></name>, <name><surname>Elliott</surname><given-names>Joshua</given-names></name>, <name><surname>Okell</surname><given-names>Lucy C</given-names></name>, <name><surname>Redd</surname><given-names>Rozlyn</given-names></name>, <name><surname>Ashby</surname><given-names>Deborah</given-names></name>, <name><surname>Donnelly</surname><given-names>Christl A.</given-names></name>, <name><surname>Barclay</surname><given-names>Wendy</given-names></name>, <name><surname>Darzi</surname><given-names>Ara</given-names></name>, <name><surname>Cooke</surname><given-names>Graham</given-names></name>, <name><surname>Riley</surname><given-names>Steven</given-names></name>, and <name><surname>Elliott</surname><given-names>Paul</given-names></name>. <article-title>Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults</article-title>. <source>medRxiv</source>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1101/2020.08.12.20173690</pub-id> URL <comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.08.12.20173690v2">https://www.medrxiv.org/content/10.1101/2020.08.12.20173690v2</ext-link>.</comment></mixed-citation>
              </ref>
              <ref id="R91">
                <label>[91]</label>
                <mixed-citation publication-type="journal"><name><surname>Young</surname><given-names>Barnaby Edward</given-names></name>, <name><surname>Ong</surname><given-names>Sean Wei Xiang</given-names></name>, <name><surname>Kalimuddin</surname><given-names>Shirin</given-names></name>, <name><surname>Low</surname><given-names>Jenny G.</given-names></name>, <name><surname>Tan</surname><given-names>Seow Yen</given-names></name>, <name><surname>Loh</surname><given-names>Jiashen</given-names></name>, <name><surname>Ng</surname><given-names>Oon-Tek</given-names></name>, <name><surname>Marimuthu</surname><given-names>Kalisvar</given-names></name>, <name><surname>Ang</surname><given-names>Li Wei</given-names></name>, <name><surname>Mak</surname><given-names>Tze Minn</given-names></name>, <name><surname>Lau</surname><given-names>Sok Kiang</given-names></name>, <name><surname>Anderson</surname><given-names>Danielle E.</given-names></name>, <name><surname>Chan</surname><given-names>Kian Sing</given-names></name>, <name><surname>Tan</surname><given-names>Thean Yen</given-names></name>, <name><surname>Ng</surname><given-names>Tong Yong</given-names></name>, <name><surname>Cui</surname><given-names>Lin</given-names></name>, <name><surname>Said</surname><given-names>Zubaidah</given-names></name>, <name><surname>Kurupatham</surname><given-names>Lalitha</given-names></name>, <name><surname>Chen</surname><given-names>Mark I-Cheng</given-names></name>, <name><surname>Chan</surname><given-names>Monica</given-names></name>, <name><surname>Vasoo</surname><given-names>Shawn</given-names></name>, <name><surname>Wang</surname><given-names>Lin-Fa</given-names></name>, <name><surname>Tan</surname><given-names>Boon Huan</given-names></name>, <name><surname>Pin Lin</surname><given-names>Raymond Tzer</given-names></name>, <name><surname>Lee</surname><given-names>Vernon Jian Ming</given-names></name>, <name><surname>Leo</surname><given-names>Yee-Sin</given-names></name>, <name><surname>Lye</surname><given-names>David Chien</given-names></name>, and for the <collab>Singapore 2019 Novel Coronavirus Outbreak Research Team</collab>. <article-title>Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore</article-title>. <source>JAMA</source>, <volume>323</volume> (<issue>15</issue>):<fpage>1488</fpage>–<lpage>1494</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32125362</pub-id></mixed-citation>
              </ref>
              <ref id="R92">
                <label>[92]</label>
                <mixed-citation publication-type="journal"><collab>The COVID-19 Investigation Team</collab>. <article-title>Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States</article-title>. <source>Nature Medicine</source>, <volume>26</volume>(<issue>6</issue>):<fpage>861</fpage>–<lpage>868</lpage>, <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1038/s41591-020-0877-5</pub-id></mixed-citation>
              </ref>
              <ref id="R93">
                <label>[93]</label>
                <mixed-citation publication-type="journal"><name><surname>Lavezzo</surname><given-names>Enrico</given-names></name>, <name><surname>Franchin</surname><given-names>Elisa</given-names></name>, <name><surname>Ciavarella</surname><given-names>Constanze</given-names></name>, <name><surname>Gina Cuomo-Dannenburg</surname><given-names>Luisa Barzon</given-names></name>, <name><surname>Claudia Del Vecchio</surname><given-names>Lucia Rossi</given-names></name>, <name><surname>Manganelli</surname><given-names>Riccardo</given-names></name>, <name><surname>Loregian</surname><given-names>Arianna</given-names></name>, <name><surname>Navarin</surname><given-names>Nicolò</given-names></name>, <name><surname>Abate</surname><given-names>Davide</given-names></name>, <name><surname>Sciro</surname><given-names>Manuela</given-names></name>, <name><surname>Merigliano</surname><given-names>Stefano</given-names></name>, <name><surname>Ettore De Canale</surname><given-names>Maria Cristina Vanuzzo</given-names></name>, <name><surname>Besutti</surname><given-names>Valeria</given-names></name>, <name><surname>Saluzzo</surname><given-names>Francesca</given-names></name>, <name><surname>Onelia</surname><given-names>Francesco</given-names></name>, <name><surname>Pacenti</surname><given-names>Monia</given-names></name>, <name><surname>Parisi</surname><given-names>Saverio G.</given-names></name>, <name><surname>Carretta</surname><given-names>Giovanni</given-names></name>, <name><surname>Donato</surname><given-names>Daniele</given-names></name>, <name><surname>Flor</surname><given-names>Luciano</given-names></name>, <name><surname>Cocchio</surname><given-names>Silvia</given-names></name>, <name><surname>Masi</surname><given-names>Giulia</given-names></name>, <name><surname>Sperduti</surname><given-names>Alessandro</given-names></name>, <name><surname>Cattarino</surname><given-names>Lorenzo</given-names></name>, <name><surname>Salvador</surname><given-names>Renato</given-names></name>, <name><surname>Nicoletti</surname><given-names>Michele</given-names></name>, <name><surname>Caldart</surname><given-names>Federico</given-names></name>, <name><surname>Castelli</surname><given-names>Gioele</given-names></name>, <name><surname>Nieddu</surname><given-names>Eleonora</given-names></name>, <name><surname>Labella</surname><given-names>Beatrice</given-names></name>, <name><surname>Fava</surname><given-names>Ludovico</given-names></name>, <name><surname>Drigo</surname><given-names>Matteo</given-names></name>, <name><surname>Gaythorpe</surname><given-names>Katy A. M.</given-names></name>, <name><surname>Brazzale</surname><given-names>Alessandra R.</given-names></name>, <name><surname>Toppo</surname><given-names>Stefano</given-names></name>, <name><surname>Trevisan</surname><given-names>Marta</given-names></name>, <name><surname>Baldo</surname><given-names>Vincenzo</given-names></name>, <name><surname>Donnelly</surname><given-names>Christl A.</given-names></name>, <name><surname>Ferguson</surname><given-names>Neil M.</given-names></name>, <name><surname>Dorigatti</surname><given-names>Ilaria</given-names></name>, <name><surname>Crisanti</surname><given-names>Andrea</given-names></name>, and <collab>Imperial College COVID-19 Response Team</collab>. <article-title>Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’</article-title>. <source>Nature</source>, <volume>584</volume>(<issue>7821</issue>):<fpage>425</fpage>–<lpage>429</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32604404</pub-id></mixed-citation>
              </ref>
              <ref id="R94">
                <label>[94]</label>
                <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>Seungjae</given-names></name>, <name><surname>Kim</surname><given-names>Tark</given-names></name>, <name><surname>Lee</surname><given-names>Eunjung</given-names></name>, <name><surname>Lee</surname><given-names>Cheolgu</given-names></name>, <name><surname>Kim</surname><given-names>Hojung</given-names></name>, <name><surname>Rhee</surname><given-names>Heejeong</given-names></name>, <name><surname>Park</surname><given-names>Se Yoon</given-names></name>, <name><surname>Son</surname><given-names>Hyo-Ju</given-names></name>, <name><surname>Yu</surname><given-names>Shinae</given-names></name>, <name><surname>Park</surname><given-names>Jung Wan</given-names></name>, <name><surname>Choo</surname><given-names>Eun Ju</given-names></name>, <name><surname>Park</surname><given-names>Suyeon</given-names></name>, <name><surname>Loeb</surname><given-names>Mark</given-names></name>, and <name><surname>Kim</surname><given-names>Tae Hyong</given-names></name>. <article-title>Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea</article-title>. <source>JAMA Internal Medicine</source>, <volume>180</volume>(<issue>11</issue>):<fpage>1447</fpage>–<lpage>1452</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32780793</pub-id></mixed-citation>
              </ref>
              <ref id="R95">
                <label>[95]</label>
                <mixed-citation publication-type="journal"><name><surname>Cevik</surname><given-names>Muge</given-names></name>, <name><surname>Kuppalli</surname><given-names>Krutika</given-names></name>, <name><surname>Kindrachuk</surname><given-names>Jason</given-names></name>, and <name><surname>Peiris</surname><given-names>Malik</given-names></name>. <article-title>Virology, transmission, and pathogenesis of SARS-CoV-2</article-title>. <source>BMJ</source>, <volume>371</volume>(<issue>m3862</issue>), <year>2020</year>. doi: <pub-id pub-id-type="doi">10.1136/bmj.m3862</pub-id></mixed-citation>
              </ref>
              <ref id="R96">
                <label>[96]</label>
                <mixed-citation publication-type="journal"><name><surname>Chaw</surname><given-names>Liling</given-names></name>, <name><surname>Koh</surname><given-names>Wee Chian</given-names></name>, <name><surname>Jamaludin</surname><given-names>Sirajul Adli</given-names></name>, <name><surname>Naing</surname><given-names>Lin</given-names></name>, <article-title>Mohammad Fathi Alikhan, and Justin Wong. Analysis of SARS-CoV-2 transmission in different settings, Brunei</article-title>. <source>Emerging infectious diseases</source>, <volume>26</volume>(<issue>11</issue>), <year>2020</year>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="F1" orientation="portrait" position="float">
              <label>Figure 1:</label>
              <caption>
                <p id="P49">Observed and estimated data used in model calibration and approximation of time-varying model parameters. Top row: A: daily new cases reported in Connecticut by the date of specimen collection among residents of non-congregate and congregate settings; B: COVID-19 hospitalization census; C: cumulative COVID-19 hospitalizations. In plots B and C, the total number (black line) represents observed data, while non-congregate (blue) and congregate (red) lines represent estimates. Middle row: D: cumulative COVID-19 deaths in Connecticut; E: hospital case fatality ratio (HFR) among hospitalized residents of non-congregate settings (estimated); F: average length of hospital stay among COVID-19 patients by month. Bottom row: G: normalized close interpersonal contact metric relative to the pre-epidemic period; H: proportion of cases 60+ years old among daily COVID-19 cases (only dataon the right of the dashed line is used in model parametrization); I: daily PCR testing volume.</p>
              </caption>
              <graphic xlink:href="nihpp-2020.06.12.20126391-f0001"/>
            </fig>
            <fig id="F2" orientation="portrait" position="float">
              <label>Figure 2:</label>
              <caption>
                <p id="P50">Schematic illustration of the model of SARS-CoV-2 transmission and COVID-19 disease progression; county map of Connecticut and county adjacency matrix. Individuals begin in the susceptible (<italic>S</italic>) compartment. Exposed individuals (<italic>E</italic>) may develop either asymptomatic (<italic>A</italic>), mild (<italic>I</italic><sub><italic>M</italic></sub>), or severe (<italic>I</italic><sub><italic>S</italic></sub>) infection. Asymptomatic and mild infections resolve without hospitalization and do not lead to death. Mild symptomatic cases self-isolate (<italic>R</italic><sub><italic>M</italic></sub>) shortly after development of symptoms, and transition to recovery (<italic>R</italic>) when infectiousness ceases. All severe cases require hospitalization (<italic>H</italic>) unless hospitalization capacity is exhausted, in which case they transition to <inline-formula><mml:math id="M1"><mml:mover accent="true"><mml:mi>H</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> representing hospital overflow, then to recovery (<italic>R</italic>) or death (<italic>D</italic>). The model captures infection transmission in non-congregate settings, and excludes cases and deaths occurring in settings like nursing homes and prisons. It assumes a closed population without births and does not capture non-COVID-19 deaths. In the adjacency matrix, the dark gray cells correspond to counties that are adjacent.</p>
              </caption>
              <graphic xlink:href="nihpp-2020.06.12.20126391-f0002"/>
            </fig>
            <fig id="F3" orientation="portrait" position="float">
              <label>Figure 3:</label>
              <caption>
                <p id="P51">Model fit to observed data and estimates of epidemiologic features of SARS-CoV-2 transmission in Connecticut. Top row shows calibration results for: A: observed COVID-19 hospitalizations census, B: cumulative hospitalizations and C: cumulative deaths in Connecticut. Observed time series are shown as points and correspond to total hospitalizations and deaths among all Connecticut residents. The model is calibrated to estimated data series coming from non-congregate settings, and model projections are adjusted by the estimated difference to reflect the totals for congregate and non-congregate settings. Middle row: D: effective reproduction number, E: normalized measure of close contact relative to the pre-epidemic period along with the spline approximation (thick solid line), and F: contact function adjusted for estimated random effects that capture residual variation in transmission that is not explained by dynamics of close contact and other time-varying parameters. For comparison, black line in plot F shows smoothed normalized close contact metric unadjusted for random effects. Bottom row: G: cumulative incidence of SARS-CoV-2 infection, H: daily new infections, and I: estimated case detection ratio in non-congregate settings in Connecticut. Solid lines represent model-projected means and shaded regions represent 95% posterior predictive intervals. Some of the plots are overlaid with the key intervention dates (lockdown and phased reopening), as well as important event dates, including reopening of schools and universities and beginning of vaccination campaign.</p>
              </caption>
              <graphic xlink:href="nihpp-2020.06.12.20126391-f0003"/>
            </fig>
            <fig id="F4" orientation="portrait" position="float">
              <label>Figure 4:</label>
              <caption>
                <p id="P52">Posterior predictive performance of the transmission model calibrated using data up to the dashed line shown in each plot and projected forward for a period of two months. Solid lines represent model-projected means and shaded regions represent 90% posterior predictive intervals. Observed data are shown as points; lighter color points correspond to the data used in calibration.</p>
              </caption>
              <graphic xlink:href="nihpp-2020.06.12.20126391-f0004"/>
            </fig>
            <table-wrap id="T1" orientation="portrait" position="float">
              <label>Table 1:</label>
              <caption>
                <p id="P53">Transmission model parameters.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1">Notation</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Definition</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>β</italic>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Transmission parameter per susceptible - infectious pair</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>δ</italic>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Latency period (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"><italic>q</italic><sub><italic>A</italic></sub>, <inline-formula><mml:math id="M2"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M3"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Proportions of infections that are asymptomatic, mild symptomatic, and severe, <inline-formula><mml:math id="M4"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>α</italic>
                      <sub>
                        <italic>A</italic>
                      </sub>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Duration of infectiousness among asymptomatic cases (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>k</italic>
                      <sub>
                        <italic>A</italic>
                      </sub>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Relative infectiousness of asymptomatic cases compared to symptomatic</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <inline-formula>
                        <mml:math id="M5">
                          <mml:mrow>
                            <mml:msub>
                              <mml:mi>α</mml:mi>
                              <mml:mrow>
                                <mml:msub>
                                  <mml:mi>I</mml:mi>
                                  <mml:mi>M</mml:mi>
                                </mml:msub>
                              </mml:mrow>
                            </mml:msub>
                          </mml:mrow>
                        </mml:math>
                      </inline-formula>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Duration of infectiousness among mild symptomatic cases, time until isolation (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <inline-formula>
                        <mml:math id="M6">
                          <mml:mrow>
                            <mml:msub>
                              <mml:mi>γ</mml:mi>
                              <mml:mrow>
                                <mml:msub>
                                  <mml:mi>R</mml:mi>
                                  <mml:mi>M</mml:mi>
                                </mml:msub>
                              </mml:mrow>
                            </mml:msub>
                          </mml:mrow>
                        </mml:math>
                      </inline-formula>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Duration of isolation among mild symptomatic cases, remaining time to recovery (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <inline-formula>
                        <mml:math id="M7">
                          <mml:mrow>
                            <mml:msub>
                              <mml:mi>α</mml:mi>
                              <mml:mrow>
                                <mml:msub>
                                  <mml:mi>I</mml:mi>
                                  <mml:mi>S</mml:mi>
                                </mml:msub>
                              </mml:mrow>
                            </mml:msub>
                          </mml:mrow>
                        </mml:math>
                      </inline-formula>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Duration of infectiousness among severe cases, time to hospitalization (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>γ</italic>
                      <sub>
                        <italic>H</italic>
                      </sub>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Length of hospital stay (time until recovery or death) (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <inline-formula>
                        <mml:math id="M8">
                          <mml:mrow>
                            <mml:msub>
                              <mml:mi>γ</mml:mi>
                              <mml:mover accent="true">
                                <mml:mi>H</mml:mi>
                                <mml:mo>¯</mml:mo>
                              </mml:mover>
                            </mml:msub>
                          </mml:mrow>
                        </mml:math>
                      </inline-formula>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1 / Remaining time until recovery or death among hospital overflow patients<sup>−1</sup> (days<sup>−1</sup>)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>m</italic>
                      <sub>
                        <italic>H</italic>
                      </sub>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Case fatality ratio among hospitalized cases (HFR)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <inline-formula>
                        <mml:math id="M9">
                          <mml:mrow>
                            <mml:msub>
                              <mml:mi>m</mml:mi>
                              <mml:mover accent="true">
                                <mml:mi>H</mml:mi>
                                <mml:mo>¯</mml:mo>
                              </mml:mover>
                            </mml:msub>
                          </mml:mrow>
                        </mml:math>
                      </inline-formula>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Case fatality ratio among hospital overflow patients</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>k</italic>
                      <sub>
                        <italic>n</italic>
                      </sub>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Proportion of all contacts that happen with individuals from adjacent counties (as opposed to within the county)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>C</italic>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Hospitalization capacity, may be constant or vary over time representing capacity increase intervention</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <italic>E</italic>
                      <sub>0</sub>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Number of exposed individuals statewide at the time of epidemic onset</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
